+
Abbott
BD, Wolf
CJ, Das
KP
et al Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse. Reprod Toxicol. 2009;27:258–265.
CrossRef +
Abbott
BD, Wolf
CJ, Schmid
JE
et al Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha. Toxicol Sci. 2007;98:571–581.
CrossRef +
Abel
EL Consumption of alcohol during pregnancy: a review of effects on growth and development of offspring. Hum Biol. 1982;54:421–453.
+
Abel
EL Factors affecting the outcome of maternal alcohol exposure: I. Parity. Neurobehav Toxicol Teratol. 1984;3:49–51.
+
Abel
EL Fetal alcohol syndrome: a cautionary note. Curr Pharm Des. 2006;12:1521–1529.
CrossRef +
Abel
EL, Church
MW, Dintcheff
BA Prenatal alcohol exposure shortens life span in rats. Teratology. 1987;36:217–220.
CrossRef +
Ackerman
JP, Riggins
T, Black
MM A review of the effects of prenatal cocaine exposure among school-aged children. Pediatrics. 2010;125:554–565.
CrossRef +
Adams
J The neurobehavioral teratology of retinoids: a 50-year history. Birth Defects Res A Clin Mol Teratol. 2010;88:895–905.
CrossRef +
Addis
A, Moretti
ME, Ahmed Syed
F
et al Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol. 2001;15:341–369.
CrossRef +
Adler
T The return of thalidomide. Sci News. 1994;146:424–425.
CrossRef +
Ahokas
RA, Dilts
PV
Jr, LaHaye
EB Cadmium-induced fetal growth retardation: protective effect of excess dietary zinc. Am J Obstet Gynecol. 1980;136:216–221.
+
Airhart
MJ, Lee
DH, Wilson
TD, Miler
BE, Miller
MN, Skalko
RG Movement disorders and neurochemical changes in zebrafish larvae after bath exposure to fluoxetine (PROZAC). Neurotoxicol Teratol. 2007;29:652–664.
CrossRef +
Alford
CA, Stagno
S, Reynolds
DW Perinatal infections caused by viruses, Toxoplasma, and Treponema pallidum. In: Aldjem S, Brown AK, eds. Clinical Perinatology. St. Louis: Mosby; 1974:31.
+
Allen
BC, Kavlock
RJ, Kimmel
CA, Faustman
EM Dose response assessment for developmental toxicity: II. Comparison of generic benchmark dose models with No Observed Adverse Effect Levels. Fundam Appl Toxicol. 1994a;23:487–495.
CrossRef +
Allen
BC, Kavlock
RJ, Kimmel
CA, Faustman
EM Dose response assessment for developmental toxicity: III. Statistical models. Fundam Appl Toxicol. 1994b;23:496–509.
CrossRef +
Amemiya
K, Hurley
LS, Keen
CL Effect of the anticarcinogenic drug 6-mercaptopurine on mineral metabolism in the mouse. Toxicol Lett. 1985;25:55–62.
CrossRef +
Amemiya
K, Hurley
LS, Keen
CL Effect of 6-mercaptopurine on 65Zn distribution in the pregnant rat. Teratology. 1989;39:387–393.
CrossRef +
Amstislavsky
SY, Amstislavskaya
TG, Amstislavsky
VS
et al Reproductive abnormalities in adult male mice following preimplantation exposures to estradiol or pesticide methoxychlor. Reprod Toxicol. 2006;21:154–159.
CrossRef +
Amstislavsky
SY, Kizilova
EA, Eroschenko
VP Preimplantation mouse embryo development as a target of the pesticide methoxychlor. Reprod Toxicol. 2003;17:79–86.
CrossRef +
Amstislavsky
SY, Kizilova
EA, Golubitsa
AN
et al Preimplantation exposures of murine embryos to estradiol or methoxychlor change postnatal development. Reprod Toxicol. 2004;18:103–108.
CrossRef +
Anway
MD, Memon
MA, Uzumcu
M, Skinner
MK Transgenerational effect of the endocrine disruptor vinclozolin on male spermatogenesis. J Androl. 2006;27:868–879.
CrossRef +
Arafa
HM, Elmazar
MM, Hamada
FM
et al Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure. Arch Toxicol. 2000;73:547–556.
CrossRef +
Argiles
JM, Carbo
N, Lopez-Soriano
FJ Was tumour necrosis factor-alpha responsible for the fetal malformations associated with thalidomide in the early 1960s? Med Hypotheses. 1998;50:313–318.
CrossRef +
Ashby
R, Davis
L, Dewhurst
BB
et al Aspects of the teratology of cyclophosphamide (NSC-26271). Cancer Treat Rep. 1976;60:477–482.
+
Auger
J, Kunstmann
JM, Czyglik
F, Jouannet
P Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med. 1995;332:281–285.
CrossRef +
Augustine
K, Liu
ET, Sadler
TW Antisense attenuation of Wnt-1 and Wnt-3a expression in whole embryo culture reveals roles for these genes in craniofacial, spinal cord, and cardiac morphogenesis. Dev Genet. 1993;14:500–520.
CrossRef +
Baer
JS, Sampson
PD, Barr
HM, Connor
PD, Streissguth
AP A 21-year longitudinal analysis of the effects of prenatal alcohol exposure on young adult drinking. Arch Gen Psychiatry. 2003;60:377–385.
CrossRef +
Bailey
GP, Marien
D The value of juvenile animal studies “What have we learned from preclinical juvenile toxicity studies?” Birth Defects Res B Dev Reprod Toxicol. 2011;92:273–291.
+
Bakker
H, Jaddoe
VW Cardiovascular and metabolic influences of fetal smoke exposure. Eur J Epidemiol. 2011;26:763–770.
CrossRef +
Balling
R, Mutter
G, Gruss
P, Kessel
M Craniofacial abnormalities induced by ectopic expression of the homeobox gene Hox-1.1 in transgenic mice. Cell. 1989;58:337–347.
CrossRef +
Bantle
JA FETAX: a developmental toxicity assay using frog embryos. In: Rand G, ed. Fundamentals of Aquatic Toxicology: Effects, Environmental Fate, Risk Assessment. 2nd ed. Washington, DC: Taylor and Francis; 1995:207–230.
+
Barlow
SM, McElhatton
PR, Sullivan
FM The relation between maternal restraint and food deprivation, plasma corticosterone, and cleft palate in the offspring of mice. Teratology. 1975;12:97–103.
CrossRef +
Barouki
R, Gluckman
PD, Grandjean
P
et al Developmental origins of non-communicable disease: implications for research and public health. Environ Health. 2012;11:42.
CrossRef +
Barrier
M, Jeffay
S, Nichols
HP
et al Mouse embryonic stem cell adherent cell differentiation and cytotoxicity (ACDC) assay. Reprod Toxicol. 2011;31:383–391.
CrossRef +
Barrow
MV A brief history of teratology to the early 20th century. Teratology. 1971;4:119–130.
CrossRef +
Bartlett
JB, Dredge
K, Dalgleish
AG The evolution of thalidomide and its imid derivatives as anticancer agents. Nat Rev Cancer. 2004;4:314–322.
CrossRef +
Bateson
W Materials for the Study of Variation Treated With Especial Regard to Discontinuity in the Origin of Species. London: Macmillan; 1894.
+
Beaty
TH, Ruczinski
I, Murray
JC
et al Evidence for gene-environment interaction in a genome wide study of nonsyndromic cleft palate. Genet Epidemiol. 2011;35:469–478.
+
Bedell
VM, Westcot
SE, Ekker
SC Lessons from morpholino-based screening in zebrafish. Brief Funct Genomics. 2011;10:181–188.
CrossRef +
Beekhuijzen
M, Zmarowski
A, Emmen
H
et al To mate or not to mate: a retrospective analysis of two-generation studies for evaluation of criteria to trigger additional mating in the extended one-generation design. Reprod Toxicol. 2009;28:203–208.
CrossRef +
Bendich
A Folic acid and neural tube defects. Introduction to Part II. Ann N. Acad Sci. 1993;678:108–111.
CrossRef +
Bennett
GD, Amore
BM, Finnell
RH
et al Teratogenicity of carbamazepine-10,11-epoxide and oxcarbazepine in the SWV mouse. J Pharmacol Exp Ther. 1996;279:1237–1242.
+
Bennett
GD, Wlodarczyk
B, Calvin
JA
et al Valproic acid-induced alterations in growth and neurotrophic factor. Reprod Toxicol. 2000;14:1–11.
CrossRef +
Beydoun
H, Saftlas
AF Physical and mental health outcomes of prenatal maternal stress in human and animal studies: a review of recent evidence. Paediatr Perinat Epidemiol. 2008;22:438–466.
CrossRef +
Beyer
PE, Chernoff
N The induction of supernumerary ribs in rodents: role of maternal stress. Teratogenesis Carcinog Mutagen. 1986;6:419–429.
CrossRef +
Bibbo
M, Gill
W, Azizi
F
et al Follow-up study of male and female offspring of DES-exposed mothers. Obstet Gynecol. 1977;49:1–8.
+
Biegel
LB, Flaws
JA, Hirshfield
AN
et al 90-day feeding and one-generation reproduction study in Crl:CD BR rats with 17 beta-estradiol. Toxicol Sci. 1998;44:116–142.
+
Boumela
I, Assou
S, Aouacheria
A
et al Involvement of BCL2 family members in the regulation of human oocyte and early embryo survival and death: gene expression and beyond. Reproduction. 2011;141:549–561.
CrossRef +
Bowman
RE Behavioral sequelae of toxicant exposure during neurobehavioral development. In: Hunt VR, Smith MK, Worth D, eds. Banbury Report 11: Environmental Factors in Human Growth and Development. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1982:283–294.
+
Branham
WS, Zehr
DR, Chen
JJ, Sheehan
DM Uterine abnormalities in rats exposed neonatally to diethylstilbestrol, ethynyl estradiol, or clomiphene citrate. Toxicology. 1998;51:201–212.
CrossRef +
Brannen
KC, Panzica-Kelly
JM, Danberry
TL
et al Development of a zebrafish embryo teratogenicity assay and quantitative prediction model. Birth Defects Res B Dev Reprod Toxicol. 2010;89:66–77.
CrossRef +
Branum
AM, Collman
GW, Correa
A
et al The National Children’s Study of environmental effects on child health and development. Environ Health Perspect. 2003;111:642–646.
CrossRef +
Brent
RL, Beckman
DA Environmental teratogens. Bull NY Acad Med. 1990;66:123–163.
+
Brown
NA Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. European Centre for the Validation of Alternative Methods. Altern Lab Anim. 2002;30:177–198.
+
Brown
NA, Fabro
S Quantitation of rat embryonic development in vitro: a morphological scoring system. Teratology. 1981;24:65–78.
CrossRef +
Bruin
JE, Gerstein
HC, Holloway
AC Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicol Sci. 2010;116:364–374.
CrossRef +
Bujan
L, Mansat
A, Pontonnier
F, Mieusset
R Time series analysis of sperm concentration in fertile men in Toulouse, France between 1977 and 1992. Br Med J. 1996;312:471–472.
CrossRef +
Cagen
SZ, Waechter
JM, Dimond
SS
et al Normal reproductive organ development in CF-1 mice following prenatal exposure to Bisphenol A. Toxicol Sci. 1999;50:36–44.
CrossRef +
Calabrese
L, Fleischer
AB Thalidomide: current and potential clinical applications. Am J Med. 2000;108:487–495.
CrossRef +
Carlsen
E, Giwercman
A, Keiding
N, Skakkebaek
NE Evidence for decreasing quality of semen during past 50 years. Br Med J. 1992;305:609–613.
CrossRef +
Carney
EW Maternally mediated developmental toxicity. In: McQueen CA, ed. Comprehensive Toxicology. 2nd ed., Vol 12. Daston GP, Knudsen TB, eds. Developmental Toxicology, New York: Elsevier; 2010:163–176.
+
Carney
EW, Scialli
AR, Watson
RE
et al Mechanisms regulating toxicant disposition to the embryo during early pregnancy: an interspecies comparison. Birth Defects Res C Embryo Today. 2004;72:345–360.
CrossRef +
Carney
EW, Sciali
AR, Watson
RE, DeSesso
JM Mechanisms regulating toxicant disposition to the embryo during early pregnancy: an interspecies comparison. Birth Defects Res Part C. 2005;72:345–360.
CrossRef +
Carney
EW, Tornesi
B, Keller
C
et al Refinement of a morphological scoring system for postimplantation rabbit conceptuses. Birth Defects Res B Dev Reprod Toxicol. 2007;80:213–222.
CrossRef +
Carruthers
CM, Foster
PM Critical window of male reproductive tract development in rats following gestational exposure to di-n-butyl phthalate. Birth Defects Res B Dev Reprod Toxicol. 2005;74:277–285.
CrossRef +
Centers for Disease Control and Prevention. Use of vitamins containing folic acid among women of childbearing age—United States, 2004. MMWR Morb Mortal Wkly Rep. 2004;36:847–850.
+
Centers for Disease Control and Prevention. MMWR. 1982;31(42):565–566.
+
Centers for Disease Control and Prevention. MMWR. 1983;32(33):438–439.
+
Chambers
CD, Scialli
A Epidemiological factors in developmental toxicology. In: McQueen CA, ed. Comprehensive Toxicology. 2nd ed., Vol 12. Daston GP, Knudsen TB, eds. Developmental Toxicology. New York: Elsevier; 2010:135–144.
+
Chambon
P The retinoid signaling pathway: molecular and genetic analyses. Semin Cell Biol. 1994;5:115–125.
CrossRef +
Chandler
KJ, Barrier
M, Jeffay
S
et al Evaluation of 309 environmental chemicals using a mouse embryonic stem cell adherent cell differentiation and cytotoxicity assay. PLoS One. 2011;6:e18540.
CrossRef +
Chandy
S, Abraham
AM, Jana
AK
et al Congenital rubella syndrome and rubella in Vellore, South India. Epidemiol Infect. 2011;139:962–966.
CrossRef +
Chapin
R, Augustine-Rauch
K, Beyer
B
et al State of the art in developmental toxicity screening methods and a way forward: a meeting report addressing embryonic stem cells, whole embryo culture, and zebrafish. Birth Defects Res B Dev Reprod Toxicol. 2008;83:446–456.
CrossRef +
Chen
M, Doherty
SD, Hsu
S Innovative uses of thalidomide. Dermatol Clin. 2010;28:577–586.
CrossRef +
Chernoff
N, Kavlock
RJ An in vivo teratology screen utilizing pregnant mice. J Environ Toxicol Health. 1982;10:541–550.
CrossRef +
Chernoff
N, Rogers
JM, Alles
AJ
et al Cell cycle alterations and cell death in cyclophosphamide teratogenesis. Teratogenesis Carcinog Mutagen. 1989;9:199–209.
CrossRef +
Chernoff
N, Setzer
RW, Miller
DM
et al Effects of chemically-induced maternal toxicity on prenatal development in the rat. Teratology. 1990;42:651–658.
CrossRef +
Clark
DO Pharmacokinetic studies in developmental toxicology: practical considerations and approaches. Toxicol Meth. 1993;3:223–251.
CrossRef +
Clark
DO, Elswick
BA, Welsch
F, Conolly
R Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: a physiologically based mathematical model. Toxicol Appl Pharmacol. 1993;121:239–252.
CrossRef +
Clark
RL, Antonello
JM, Grosman
SJ
et al External genitalia abnormalities in male rats exposed in utero to finasteride, a 5α-reductase inhibitor. Teratology. 1990;42:91–100.
CrossRef +
Clark
RL, Robertson
RT, Minsker
DH
et al Diflunisal-induced maternal anemia as a cause of teratogenicity in rabbits. Teratology. 1984;30:319–332.
CrossRef +
Clarren
SK, Sampson
PD, Larsen
J
et al Facial effects of fetal alcohol exposure: assessment by photographs and morphometric analysis. Am J Med Genet. 1987;26:651–666.
CrossRef +
Claudio
L, Bearer
CF, Wallinga
D Assessment of the US Environmental Protection Agency methods for identification of hazards to developing organisms: Part II. The developmental toxicity testing guideline. Am J Ind Med. 1999;35:554–563.
CrossRef +
Cohlan
SQ Congenital anomalies in the rat produced by excessive intake of vitamin A during pregnancy. Pediatrics. 1954;13:556–567.
+
Collins
MD, Mao
GE Teratology of retinoids. Annu Rev Pharmacol Toxicol. 1999;39:399–430.
CrossRef +
Cook
JC, Johnson
L, O’Connor
JC
et al Effects of dietary 17β-estradiol exposure on serum hormone concentrations and testicular parameters in male Crl:CD BR rats. Toxicol Sci. 1998;44:155–168.
+
Cooper
LZ, Krugman
S Diagnosis and management: congeneital rubella. Pediatrics. 1966;37:335–342.
+
Cooper
RL Current developments in reproductive toxicity testing of pesticides. Reprod Toxicol. 2009;28:180–187.
CrossRef +
Cooper
WO, Hernandez-Diaz
S, Arbogast
PG
et al Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354:2443–2451.
CrossRef +
Corley
RA Pharmacokinetics and PBPK models. In: McQueen CA, ed. Comprehensive Toxicology. 2nd ed., Vol 12. Daston GP, Knudsen TB, eds. Developmental Toxicology. New York: Elsevier; 2010:27–58.
+
Corley
RA, Mast
TJ, Carney
EW, Rogers
JM, Daston
GP Evaluation of physiologically based models of pregnancy and lactation for their application in children’s health risk assessments. Crit Rev Toxicol. 2003;33:137–211.
CrossRef +
Corley
RA, Meek
ME, Carney
EW Mode of action: oxalate crystal-induced renal tubule degeneration and glycolic acid-induced dysmorphogenesis—renal and developmental effects of ethylene glycol. Crit Rev Toxicol. 2005;35:691–702.
CrossRef +
Craig
JC, Bennett
GD, Miranda
RC
et al Ribonucleotide reductase subunit R1: a gene conferring sensitivity to valproic acid-induced neural tube defects in mice. Teratology. 2000;61:305–313.
CrossRef +
Crump
KS A new method for determining allowable daily intakes. Fundam Appl Toxicol. 1984;4:854–871.
CrossRef +
Cupul-Uicab
LA, Baird
DD, Skjaerven
R, Saha-Chaudhuri
P, Haug
K, Longnecker
MP In utero exposure to maternal smoking and women’s risk of fetal loss in the Norwegian mother and child cohort (MoBa). Environ Health Perspect. 2012;120:355–360.
CrossRef +
Czeizel
AE Periconceptional folic acid-containing multivitamin supplementation for the prevention of neural tube defects and cardiovascular malformations. Ann Nutr Metab. 2011;59:38–40.
CrossRef +
Czeizel
AE, Dudas
I, Paput
L
et al Prevention of neural-tube defects with periconceptional folic acid, methylfolate, or multivitamins? Ann Nutr Metab. 2011;58:263–271.
CrossRef +
D’Amato
RJ, Loughman
MS, Flynn
E, Folkman
J Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci. 1994;91:4082–4085.
CrossRef +
Dai
WS, LaBraico
JM, Stern
RS Epidemiology of isotretinoin exposure during pregnancy. J Am Acad Dermatol. 1992;26:599–606.
CrossRef +
Dareste
C Récherches sur la production artificielle des monstruositiés, ou essais de tératogénie expérimentale. Paris: Reinwald; 1877.
+
Dareste
C Récherches sur la production artificielle des monstruositiés, ou essais de tératogénie expérimentale. 2nd ed. Paris: Reinwald; 1891.
+
Daston
GP Fetal zinc deficiency as a mechanism for cadmium-induced toxicity to the developing rat lung and pulmonary surfactant. Toxicology. 1982;24:55–63.
CrossRef +
Daston
GP Do thresholds exist for developmental toxicants? A review of the theoretical and experimental evidence. In: Kalter H, ed. Issues and Review in Teratology. New York: Plenum Press; 1993:169–197.
+
Daston
GP Relationships between maternal and developmental toxicity. In: Kimmel CA, Buelke-Sam J, eds. Developmental Toxicology. 2nd ed. New York: Raven Press; 1994:189–212.
+
Daston
GP The theoretical and empirical case for in vitro developmental toxicity screens, and potential applications. Teratology. 1996;53:339–344.
CrossRef +
Daston
GP, Knudsen
TB Fundamental concepts, current regulatory design and interpretation. In: McQueen CA, ed. Comprehensive Toxicology. 2nd ed., Vol 12. Daston GP, Knudsen TB, eds. Developmental Toxicology. New York: Elsevier; 2010:3–9.
+
Daston
GP, Overmann
GJ, Taubeneck
MW, Lehman-Mckeeman
LD, Rogers
JM, Keen
CL The role of metallothionein induction and altered zinc status in maternally mediated developmental toxicity: comparison of the effects of urethane and styrene in rats. Toxicol Appl Pharmacol. 1991;110:450–463.
CrossRef +
Davis
JA, Gift
JS, Zhao
QJ Introduction to benchmark dose methods and U.S. EPA’s benchmark dose software (BMDS) version 2.1.1. Toxicol Appl Pharmacol. 2011;254:181–191.
CrossRef +
de Mouzon
J, Thonneau
P, Spira
A, Multigner
L Semen quality has declined among men born in France since 1950. Br Med J. 1996;313:43.
CrossRef +
De Santis
M, Cavaliere
AF, Straface
G, Caruso
A Rubella infection in pregnancy. Reprod Toxicol. 2006;21:390–398.
CrossRef +
Deschamps
J, van Nes
J Developmental regulation of the Hox genes during axial morphogenesis in the mouse. Development. 2005;132:2931–2942.
CrossRef +
DeSesso
JM Maternal factors in developmental toxicity. Teratogenesis Carcinog Mutagen. 1987;7:225–240.
CrossRef +
Diamanti-Kandarakis
E, Bourguignon
JP, Giudice
LC
et al Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30:293–342.
CrossRef +
Dietert
RR Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment. J Immunotoxicol. 2008;5:401–412.
CrossRef +
Dietrich
M, Brown
CJ, Block
G The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J Am Coll Nutr. 2005;24:266–274.
CrossRef +
Doering
PL, Boothby
LA, Cheok
M Review of pregnancy labeling of prescription drugs: is the current system adequate to inform of risks? Am J Obstet Gynecol. 2002;187:333–339.
CrossRef +
Dolinoy
DC, Weidman
JR, Waterland
RA, Jirtle
RL Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect. 2006;114:567–572.
CrossRef +
Downing
C, Biers
J, Larson
C
et al Genetic and maternal effects on valproic acid teratogenesis in C57BL/6J and DBA/2J mice. Toxicol Sci. 2010;116:632–639.
CrossRef +
Dreosti
IE Nutritional factors underlying the expression of the fetal alcohol syndrome. Ann NY Acad Sci. 1993;678:193–204.
CrossRef +
Dunkel Schetter
C, Tanner
L Anxiety, depression and stress in pregnancy: implications for mothers, children, research, and practice. Curr Opin Psychiatry. 2012;25:141–148.
CrossRef +
Dupe
V, Ghyselinck
NB, Thomazy
V
et al Essential roles of retinoic acid signaling in interdigital apoptosis and control of BMP-7 expression in mouse autopods. Dev Biol. 1999;208:30–43.
CrossRef +
Edwards
MJ Hyperthermia as a teratogen: a review of experimental studies and their clinical significance. Teratog Carcinog Mutag. 1986;6:563–582.
CrossRef +
Edwards
MJ Hyperthermia and fever during pregnancy. Birth Defects Res A Clin Mol Teratol. 2006;76:507–516.
CrossRef +
Ehlers
K, Sturje
H, Merker
HJ
et al Valproic acid-induced spina bifida: a mouse model. Teratology. 1992a;45:145–154.
CrossRef +
Ehlers
K, Sturje
H, Merker
H-J, Nau
H Spina bifida aperta induced by valproic acid and by all-
trans-retinoic acid in the mouse: distinct differences in morphology and periods of sensitivity. Teratology. 1992b;46:117–130.
CrossRef +
Eibs
HG, Speilman
H, Hagele
M Teratogenic effects of cyproterone acetate and medroxyprogesterone treatment during the pre- and postimplantation period of mouse embryos. Teratology. 1982;25:27–36.
CrossRef +
Eikel
D, Lampen
A, Nau
H Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives. Chem Res Toxicol. 2006;19:272–278.
CrossRef +
Ellis-Hutchings
RG, Carney
EW Whole embryo culture: a “New” technique that enabled decades of mechanistic discoveries. Birth Defects Res B Dev Reprod Toxicol. 2010;89:304–312.
CrossRef +
Elstein
KH, Zucker
RM, Andrews
JE
et al Effects of developmental stage and tissue type on embryo/fetal DNA distributions and 5-fluorouracil-induced cell-cycle perturbations. Teratology. 1993;48:355–363.
CrossRef +
Entringer
S, Buss
C, Wadhwa
PD Prenatal stress and developmental programming of human health and disease risk: concepts and integration of empirical findings. Curr Opin Endocrinol Diabetes Obes. 2010;17:507–516.
CrossRef +
Eriksson
P, Lundkvist
U, Fredricksson
A Neonatal exposure to 3,4,3′,4′-tetrachlorobiphenyl: changes in spontaneous behavior and cholinergic muscarinic receptors in the adult mouse. Toxicology. 1991;69:27–34.
CrossRef +
Ernhart
CB, Sokol
RJ, Martier
S
et al Alcohol teratogenicity in the human: a detailed assessment of specificity, critical period and threshold. Am J Obstet Gynecol. 1987;156:33–39.
CrossRef +
Euker
JS, Riegle
GD Effect of stress on pregnancy in the rat. J Reprod Fertil. 1973;34:343–346.
CrossRef +
Fabro
S Passage of drugs and other chemicals into the uterine fluids and preimplantation blastocyst. In: Boreus L, ed. Fetal Pharmacology. New York: Raven Press; 1973:443–461.
+
Fabro
S, McLachlan
JA, Dames
NM Chemical exposure of embryos during the preimplantation stages of pregnancy: mortality rate and intrauterine development. Am J Obstet Gynecol. 1984;148:929–938.
CrossRef +
Faiella
A, Wernig
M, Consalez
GG
et al A mouse model for valproate teratogenicity: parental effects, homeotic transformations, and altered HOX expression. Hum Mol Genet. 2000;9:227–236.
CrossRef +
Fantel
AG, Greenaway
JC, Juchau
MR, Shepard
TH Teratogenic bioactivation of cyclophosphamide in vitro. Life Sci. 1979;25:67–72.
CrossRef +
Faustman
EM, Allen
BC, Kavlock
RJ, Kimmel
CA Dose response assessment for developmental toxicity: I. Characterization of database and determination of No Observed Adverse Effect Levels. Fundam Appl Toxicol. 1994;23:478–486.
CrossRef +
Ferm
VH, Carpenter
SJ Teratogenic effect of cadmium and its inhibition by zinc. Nature. 1967;216:1123.
CrossRef +
Ferm
VH, Carpenter
SJ The relationship of cadmium and zinc in experimental mammalian teratogenesis. Lab Invest. 1968;18:429–432.
+
Finnell
RH, Gelineau-van Waes
J, Bennett
GD
et al Genetic basis of susceptibility to environmentally induced neural tube defects. Ann NY Acad Sci. 2000;919:261–277.
CrossRef +
Finnell
RH, Wlodarczyk
BC, Craig
JC
et al Strain-dependent alterations in the expression of folate pathway genes following teratogenic exposure to valproic acid in a mouse model. Am J Med Genet. 1997;70:303–311.
CrossRef +
Fisch
H, Goluboff
ET Geographic variation in sperm counts: a potential cause of bias in studies of semen quality. Fertil Steril. 1996;65:1044–1046.
+
Fisher
JW, Whitaker
TA, Taylor
DH
et al Physiologically based pharmocokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. Toxicol Appl Pharmacol. 1989;99:395–414.
CrossRef +
Fleming
P, Blair
PS Sudden infant death syndrome and parental smoking. Early Hum Dev. 2007;83:721–725.
CrossRef +
Fort
DJ, Paul
RR Enhancing the predictive validity of Frog Embryo Teratogenesis Assay—Xenopus (FETAX). J Appl Toxicol. 2002;22:185–191.
CrossRef +
Fort
DJ, Rogers
RL, Thomas
JH, Buzzard
BO, Noll
AM, Spaulding
CD Comparative sensitivity of
Xenopus tropicalis and
Xenopus laevis as test species for the FETAX model. J Appl Toxicol. 2004;24:443–457.
CrossRef +
Fort
DJ, Stover
EL, Farmer
DR, Lemen
JK Assessing the predictive validity of frog embryo teratogenesis assay—
Xenopus (FETAX). Teratogenesis Carcinog Mutagen. 2000;20:87–98.
CrossRef +
Foster
PM Mode of action: impaired fetal leydig cell function—effects on male reproductive development produced by certain phthalate esters. Crit Rev Toxicol. 2005;35:713–719.
CrossRef +
Francis
BM, Rogers
JM, Sulik
KK
et al Cyclophosphamide teratogenesis: evidence for compensatory responses to induced cellular toxicity. Teratology. 1990;42:473–482.
CrossRef +
Frankos
VH FDA perspectives on the use of teratology data for human risk assessment. Fundam Appl Toxicol. 1985;5:615–622.
CrossRef +
Fraysse
B, Mons
R, Garric
J Development of a zebrafish 4-day embryo-larval bioassay to assess toxicity of chemicals. Ecotoxicol Environ Saf. 2006;63:253–267.
CrossRef +
Fried
PA, Watkinson
B, Gray
R Differential effects on cognitive functioning in 9- to 12-year olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol. 1998;20:293–306.
CrossRef +
Friedman
JM ACE inhibitors and congenital anomalies. N Engl J Med. 2006;354:2498–2500.
CrossRef +
Friedman
JM How do we know if an exposure is actually teratogenic in humans? Am J Med Genet C Semin Med Genet. 2011;157:170–174.
CrossRef +
Fullerton
PM, Kermer
M Neuropathy after intake of thalidomide. Br Med J. 1961;2:855–858.
CrossRef +
Gabrielson
JL, Larson
KS Proposals for improving risk assessment in reproductive toxicology. Pharmacol Toxicol. 1990;66:10–17.
CrossRef +
Gabrielson
JL, Paalkow
LK A physiological pharmacokinetic model for morphine disposition in the pregnant rat. J Pharmacokinet Biopharm. 1983;11:147–163.
CrossRef +
Gargas
ML, Tyler
TR, Sweeney
LM
et al A toxicokinetic study of inhaled ethylene glycol monomethyl ether (2-ME) and validation of a physiologically based pharmacokinetic model for the pregnant rat and human. Toxicol Appl Pharmacol. 2000;165:53–62.
CrossRef +
Gaylor
DW, Chen
JJ Dose response models for developmental malformations. Teratology. 1993;47:291–297.
CrossRef +
Gaylor
DW, Razzaghi
M Process of building biologically based dose response models for developmental defects. Teratology. 1992;46:573–581.
CrossRef +
Gaylor
DW, Sheehan
DM, Young
JF, Mattison
DR The threshold dose question in teratogenesis. Teratology. 1988;38:389–391.
CrossRef +
Gellert
RJ Kepone, mirex, dieldrin and aldrin: estrogenic activity and the induction of persistent vaginal estrus and anovulation in rats following prenatal treatment. Environ Res. 1978;16:131–138.
CrossRef +
Generoso
WM, Rutledge
JC, Cain
KT
et al Exposure of female mice to ethylene oxide within hours after mating leads to fetal malformations and death. Mutat Res. 1987;176:269–274.
CrossRef +
Generoso
WM, Rutledge
JC, Cain
KT
et al Mutagen-induced fetal anomalies and death following treatment of females within hours after mating. Mutat Res. 1988;199:175–181.
CrossRef +
Genschow
E, Scholz
G, Brown
N
et al Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study. In Vitro Mol Toxicol. 2000;13:51–65.
+
Genschow
E, Spielmann
H, Scholz
G
et al The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods. Altern Lab Anim. 2002;30:151–176.
+
Genschow
E, Spielmann
H, Scholz
G
et al Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim. 2004;32:209–244.
+
George
L, Granath
F, Johansson
AL, Anneren
G, Cnattingius
S Environmental tobacco smoke and risk of spontaneous abortion. Epidemiology. 2006;17:500–505.
CrossRef +
Gilbert
ME Impact of low-level thyroid hormone disruption induced by propylthiouracil on brain development and function. Toxicol Sci. 2011;124:432–445.
CrossRef +
Gilliland
FD, Berhane
K, McConnell
R
et al Maternal smoking during pregnancy, environmental tobacco smoke exposure and childhood lung function. Thorax. 2000;55:271–276.
CrossRef +
Gluckman
PD, Hanson
MA, Low
FM The role of developmental plasticity and epigenetics in human health. Birth Defects Res C Embryo Today. 2011;93:12–18.
CrossRef +
Goldey
ES, Crofton
KM Thyroxine replacement attentuates hypothyroxinemia, hearing loss and motor deficits following developmental exposure to Arochlor 1254 in rats. Toxicol Sci. 1998;45:94–105.
+
Goldey
ES, Kehn
LS, Lau
C
et al Developmental exposure to polychlorinated biphenyls (Arochlor 1254) reduces circulating thyroid hormone concentrations and causes hearing deficits in rats. Toxicol Appl Pharmacol. 1995;135:77–88.
CrossRef +
Gomes-Carneiro
MR, De-Oliveira
AC, De-Carvalho
RR
et al Inhibition of cyclophosphamide-induced teratogenesis by beta-ionone. Toxicol Lett. 2003;138:205–213.
CrossRef +
Gorsuch
RL, Key
MK Abnormalities of pregnancy as a function of anxiety and life stress. Psychosom Med. 1974;36:352–362.
CrossRef +
Gouin
K, Murphy
K, Shah
PS
et al Effects of cocaine use during pregnancy on low birth weight and preterm birth: systematic review and metaanalyses. Am J Obstet Gynecol. 2011;204:340e1–340e12.
CrossRef +
Grace
CE, Kim
SJ, Rogers
JM Maternal influences on epigenetic programming of the developing hypothalamic-pituitary-adrenal axis. Birth Defects Res A Clin Mol Teratol. 2011;91:797–805.
CrossRef +
Graham
A, Papoalopulu
N, Krumlauf
R The murine and
Drosophila homeobox gene complexes have common features of organization and expression. Cell. 1989;57:367–378.
CrossRef +
Gray
LE, Ostby
J, Ferrell
J
et al A dose–response analysis of methoxychlor-induced alterations of reproductive development and function in the rat. Fundam Appl Toxicol. 1989;12:92–108.
CrossRef +
Gray
LE, Ostby
JS, Kelce
WR Developmental effects of an environmental anti-androgen: the fungicide vinclozolin alters sex differentiation of the male rat. Toxicol Appl Pharmacol. 1994;129:46–52.
CrossRef +
Gray
LE, Ostby
J, Kelce
WR A dose–response analysis of the reproductive effects of a single gestational dose of 2,3,7,8-tetrachloro-p-dioxin (TCDD) in male Long Evans Hooded rat offspring. Toxicol Appl Pharmacol. 1997a;146:11–20.
CrossRef +
Gray
LE, Wold
C, Mann
P, Ostby
JS In utero exposure to low doses of 2,3,7,8-tetrachloro-p-dioxin (TCDD) alters reproductive development of female Long Evans Hooded rat offspring. Toxicol Appl Pharmacol. 1997b;146:237–244.
CrossRef +
Gregg
NM Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust. 1941;3:35–40.
+
Guenther
TM, Mannering
GT Induction of hepatic monooxygenase systems of pregnant rats with phenobarbital and 3-methylcholanthrene. Biochem Pharmacol. 1977;26:577–584.
CrossRef +
Guo
YL, Lin
CJ, Yao
WJ, Ryan
JJ, Hsu
CC Musculoskeletal changes in children prenatally exposed to polychlorinated biphenyls and related compounds (Yu-Cheng children). J Toxicol Environ Health. 1994;41:83–93.
CrossRef +
Guzelian
PS Comparative toxicology of chlordecone (kepone) in humans and experimental animals. Annu Rev Pharmacol Toxicol. 1982;22:89–113.
CrossRef +
Guzelian
PS, Henry
CJ, Olin
SS eds. Similarities and Differences Between Children & Adults: Implications for Risk Assessment. Washington, DC: ILSI Press; 1992.
+
Hackshaw
A, Rodeck
C, Boniface
S Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. Hum Reprod Update. 2011;17:589–604.
CrossRef +
Hale
F Pigs born without eyeballs. J Hered. 1935;27:105–106.
+
Hales
B Comparison of the mutagenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard and acrolein. Cancer Res. 1982;42:3018–3021.
+
Hales
B Relative mutagenicity and teratogenicity of cyclophosphamide and two of its structural analogs. Biochem Pharmacol. 1983;32:3791–3795.
CrossRef +
Hales
BF Modification of the teratogenicity and mutagenicity of cyclophosphamide with thiol compounds. Teratology. 1981;23:373–381.
CrossRef +
Hales
BF Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro. Teratology. 1989;40:11–20.
CrossRef +
Hales
BF, Grenier
L, Lalancette
C
et al Epigenetic programming: from gametes to blastocyst. Birth Defects Res A Clin Mol Teratol. 2011;91:652–665.
CrossRef +
Hall
DL, Payne
LA, Putnam
JM
et al Effect of methoxychlor on implantation and embryo development in the mouse. Reprod Toxicol. 1997;11:703–708.
CrossRef +
Handler
A, Davis
F, Ferre
C, Yeko
T The relationship of smoking and ectopic pregnancy. Am J Public Health. 1989;79:1239–1242.
CrossRef +
Hannas
BR, Lambright
CS, Furr
J
et al Dose-response assessment of fetal testosterone production and gene expression levels in rat testes following in utero exposure to diethylhexyl phthalate, diisobutyl phthalate, diisoheptyl phthalate, and diisononyl phthalate. Toxicol Sci. 2011;123:206–216.
CrossRef +
Hansen
DK Developmental toxicity of antiepileptic drugs. In: McQueen CA, ed. Comprehensive Toxicology. 2nd ed., Vol 12. Daston GP, Knudsen TB, eds. Developmental Toxicology. New York: Elsevier; 2010:177–187.
+
Hansen
DK, Billings
RE Phenytoin teratogenicity and effects on embryonic and maternal folate metabolism. Teratology. 1985;31:363–371.
CrossRef +
Hansen
DK, Dial
SL, Terry
KK
et al In vitro embryotoxicity of carbamazepine and carbamazepine-10, 11-epoxide. Teratology. 1996;54:45–51.
CrossRef +
Hansen
DK, Hodes
ME Comparative teratogenicity of phenytoin among several inbred strains of mice. Teratology. 1983;28:175–179.
CrossRef +
Hansen
JM, Carney
EW, Harris
C Differential alteration by thalidomide of the glutathione content of rat vs rabbit conceptuses in vitro. Reprod Toxicol. 1999;13:547–554.
CrossRef +
Hansen
JM, Harris
C A novel hypothesis for thalidomide-induced limb teratogenesis: redox misregulation of the NF-kappaB pathway. Antioxid Redox Signal. 2004;6:1–14.
CrossRef +
Hansen
JM, Harris
KK, Philbert
MA, Harris
C Thalidomide modulates nuclear redox status and preferentially depletes glutathione in rabbit limb versus rat limb. J Pharmacol Exp Ther. 2002;300:768–776.
CrossRef +
Hanson
JW, Smith
DW The fetal hydantoin syndrome. J Pediatr. 1975;87:285–290.
CrossRef +
Hardin
BD, Becker
RJ, Kavlock
RJ
et al Overview and summary: workshop on the Chernoff/Kavlock preliminary developmental toxicity test. Teratogenesis Carcinog Mutagen. 1987;7:119–127.
CrossRef +
Hartig
PC, Hunter
ES
III Gene delivery to the neurulating embryo during culture. Teratology. 1998;58:103–112.
CrossRef +
Hauck
R-S, Nau
H The enantiomers of the valproic acid analogue 2-
n-propylpentyoic acid (4-yn-VPA): Asymmetric synthesis and highly stereoselective teratogenicity in mice. Pharm Res. 1992;9:850–854.
CrossRef +
Haug
K, Irgens
LM, Skjaerven
R
et al Maternal smoking and birthweight: effect modification of period, maternal age and paternal smoking. Acta Obstet Gynecol Scand. 2000;79:485–489.
CrossRef +
Hays
SM, Elswick
BA, Blumenthal
GM
et al Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats. Toxicol Appl Pharmacol. 2000;163:67–74.
CrossRef +
Heinrichs
WL, Gellert
RJ, Bakke
JL, Lawrence
NL DDT administered to neonatal rats induces persistent estrus syndrome. Science. 1971;173:642–643.
CrossRef +
Helene
C, Toulme
JJ Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta. 1990;1049:99–125.
CrossRef +
Hellemans
KG, Sliwowska
JH, Verma
P
et al Prenatal alcohol exposure: fetal programming and later life vulnerability to stress, depression and anxiety disorders. Neurosci Biobehav Rev. 2010;34:791–807.
CrossRef +
Helm
FC, Frankus
E, Friderichs
E
et al Comparative teratological investigation of compounds structurally related to thalidomide. Arnz Forsch Drug Res. 1981;31:941–949.
+
Herbst
AL, Cole
P, Colton
T
et al Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1977;128:43–50.
+
Hernandez-Martinez
R, Covarrubias
L Interdigital cell death function and regulation: new insights on an old programmed cell death model. Dev Growth Differ. 2011;53:245–258.
CrossRef +
Higuchi
TT, Palmer
JS, Gray
LE
Jr, Veeramachaneni
DN Effects of dibutyl phthalate in male rabbits following in utero, adolescent, or postpubertal exposure. Toxicol Sci. 2003;72:301–313.
CrossRef +
Hirsch
KS, Scott
WJ
Jr Searching for the mechanism of acetazolamide teratogenesis. In: Kalter H, ed. Issues and Reviews in Teratology. Vol 1. New York: Plenum Press; 1983:309–347.
+
Holladay
SD, Luster
MI Developmental immunotoxicology. In: Kimmel CA, Buelke-Sam J, eds. Developmental Toxicology. 2nd ed. New York: Raven Press; 1994:93–117.
+
Holson
JF, Stump
DG, Pearce
LB, Watson
RE, DeSesso
JM Mode of action: yolk sac poisoning and impeded histiotrophic nutrition—HBOC-related congenital malformations. Crit Rev Toxicol. 2005;35:739–745.
CrossRef +
Hotchkiss
AK, Rider
CV, Furr
J
et al In utero exposure to an AR antagonist plus an inhibitor of fetal testosterone synthesis induces cumulative effects on F1 male rats. Reprod Toxicol. 2010;30:261–270.
CrossRef +
Hsu
S-T, Ma
C-I, Hsu
SK
et al Discovery and epidemiology of PCB poisoning in Taiwan: a four-year followup. Environ Health Perspect. 1985;59:5–10.
CrossRef +
Huang
WW, Yin
Y, Bi
Q
et al Developmental diethylstilbestrol exposure alters genetic pathways of uterine cytodifferentiation. Mol Endocrinol. 2005;19:669–682.
CrossRef +
Hurtt
ME, Daston
G, Davis-Bruno
K
et al Juvenile animal studies: testing strategies and design. Birth Defects Res B Dev Reprod Toxicol. 2004;71:281–288.
CrossRef +
Hytten
FE Physiologic changes in the mother related to drug handling. In: Krauer B, Hytten F, del Pozo E, eds. Drugs and Pregnancy. New York: Academic Press; 1984:7–17.
+
Imperato-McGinley
J, Sanchez
R, Spencer
JR, Yee
B, Vaughan
ED Comparison of the effects of the 5α-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose–response studies. Endocrinology. 1992;131:1149–1156.
+
Irl
C, Hasford
J Assessing the safety of drugs in pregnancy: the role of prospective cohort studies. Drug Saf. 2000;22:169–177.
CrossRef +
Irvine
S, Cawood
E, Richardson
D
et al Evidence of deteriorating semen quality in the United Kingdom: birth cohort study in 577 men in Scotland over 11 years. Br Med J. 1996;312:467–471.
CrossRef +
Ito
T, Ando
H, Handa
H Teratogenic effects of thalidomide: molecular mechanisms. Cell Mol Life Sci. 2011;68:1569–1579.
CrossRef +
Ito
T, Handa
H Deciphering the mystery of thalidomide teratogenicity. Congenit Anom (Kyoto). 2012;52:1–7.
CrossRef +
Jacobson
J, Jacobson
S, Humphrey
H Effects of exposure to PCBs and related compounds on growth and activity in children. Neurotoxicol Teratol. 1990;12:319–326.
CrossRef +
Jacobson
J, Jacobson
S Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N Engl J Med. 1996;335:783–789.
CrossRef +
Jelovsek
FR, Mattison
DR, Chen
JJ Prediction of risk for human developmental toxicity: how important are animal studies for hazard identification? Obstet Gynecol. 1989;74:624–636.
+
Jones
KL The effects of alcohol on fetal development. Birth Defects Res C Embryo Today. 2011;93:3–11.
CrossRef +
Jones
KL, Smith
DW Recognition of the fetal alcohol syndrome in early infancy. Lancet. 1973;2:999–1001.
CrossRef +
Jones
KL, Smith
DW, Ulleland
CN, Streissguth
AP Pattern of malformation in offspring of chronic alcoholic mothers. Lancet. 1973;1:1267–1271.
CrossRef +
Jonsson
NA Chemical structure and teratogenic properties. Acta Pharm Sueccia. 1972;9:521–542.
+
Joussen
AM, Germann
T, Kirchhof
B Effect of thalidomide and structurally related compounds on cornela angiogenesis is comparable to their teratological potency. Graefes Arch Clin Exp Ophthalmol. 1999;237:952–961.
CrossRef +
Juchau
MR Enzymatic bioactivation and inactivation of chemical teratogens and transplacental carcinogens/mutagens. In: Juchau MR, ed. The Biochemical Basis of Chemical Teratogenesis. New York: Elsevier/North Holland; 1981:63–94.
+
Juchau
MR, Faustman-Watts
EM Pharmacokinetic considerations in the maternal-placental unit. Clin Obstet Gynecol. 1983;26:379–390.
CrossRef +
Juchau
MR, Lee
QP, Fantel
AG Xenobiotic biotransformation/ bioactivation in organogenesis-stage conceptual tissues: implications for embryotoxicity and teratogenesis. Drug Metab Rev. 1992;24:195–238.
CrossRef +
Juriloff
DM, Fraser
FC Genetic maternal effects on cleft lip frequency in A/J and CL/Fr mice. Teratology. 1980;21:167–175.
CrossRef +
Jurisicova
A, Acton
BM Deadly decisions: the role of genes regulating programmed cell death in human preimplantation embryo development. Reproduction. 2004;128:281–291.
CrossRef +
Kang
H-G, Lee
C-H, Lee
K-C
et al. Effects of butylated hydroxyanisole on glutathione S-transferase activity and cyclophosphamide-induced teratogenicity in rats. J Toxicol Pub Health. 2003;19:181–187.
+
Kavlock
R, Chandler
K, Houck
K
et al Update on EPA’s ToxCast program: providing high throughput decision support for chemical risk management. Chem Res Toxicol. 2012;25:1287–1302.
CrossRef +
Kavlock
R, Cummings
A Mode of action: inhibition of androgen receptor function—vinclozolin-induced malformations in reproductive development. Crit Rev Toxicol. 2005;35:721–726.
CrossRef +
Kavlock
RJ, Allen
BC, Faustman
EM, Kimmel
CA Dose response assessment for developmental toxicity: IV. Benchmark doses for fetal weight changes. Fundam Appl Toxicol. 1995;26:211–222.
CrossRef +
Kavlock
RJ, Chernoff
N, Rogers
EH The effect of acute maternal toxicity on fetal development in the mouse. Teratogenesis Carcinog Mutagen. 1985;5:3–13.
CrossRef +
Kavlock
RJ, Daston
GP, DeRosa
D
et al Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the US EPA-sponsored workshop. Environ Health Perspect. 1996;104(suppl 4):715–740.
CrossRef +
Keen
CL, Bendich
A, Willhite
CC eds. Maternal Nutrition and Pregnancy Outcome. Ann NY Acad Sci 1993;678:1–372.
CrossRef +
Keen
CL, Peters
JM, Hurley
LS The effect of valproic acid on 65Zn distribution in the pregnant rat. J Nutr. 1989;119:607–611.
+
Keen
CL, Uriu-Adams
JY, Skalny
A
et al The plausibility of maternal nutritional status being a contributing factor to the risk for fetal alcohol spectrum disorders: The potential influence of zinc status as an example. Biofactors. 2010;36:125–135.
+
Kelce
WR, Stone
CR, Laws
SC
et al Persistent DD. metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature. 1995;375:581–585.
CrossRef +
Kelsey
FO Thalidomide update: regulatory aspects. Teratology. 1988;38:221–226.
CrossRef +
Kessel
M, Balling
R, Gruss
P Variations of cervical vertebrae after expression of a Hox-1.1 transgene in mice. Cell. 1990;61:301–308.
CrossRef +
Khera
KS Maternal toxicity: a possible etiological factor in embryo/fetal deaths and fetal malformations of rodent-rabbit species. Teratology. 1985;31:129–153.
CrossRef +
Khera
KS Maternal toxicity—a possible factor in fetal malformations in mice. Teratology. 1984;29:411–416.
CrossRef +
Khoury
MJ, Erickson
JD, James
LM Maternal factors in cleft lip with or without palate: evidence from interracial crosses in the United States. Teratology. 1983;27:351–357.
CrossRef +
Khoury
MJ, Holtzman
NA On the ability of birth defects monitoring systems to detect new teratogens. Am J Epidemiol. 1987;126:136–143.
+
Khoury
MJ, James
LM, Lynberg
MC Quantitative analysis of associations between birth defects and suspected human teratogens. Am J Med Genet. 1991;40:500–505.
CrossRef +
Kim
H-J, Lee
J-E, Choi
E-K, Kim
Y-B Effects of butylated hydroxyanisole on glutathione S-transferase activity and teratogenicity of cyclophosphamide in mice. Korean J Lab Anim Sci. 2003;19:120–125.
+
Kimmel
CA, Collman
GW, Fields
N, Eskenazi
B Lessons learned for the National Children’s Study from the National Institute of Environmental Health Sciences/U.S. Environmental Protection Agency Centers for Children’s Environmental Health and Disease Prevention Research. Environ Health Perspect. 2005;113:1414–1418.
CrossRef +
Kimmel
CA, Cook
RO, Staples
RE Teratogenic potential of noise in rats and mice. Toxicol Appl Pharmacol. 1976;36:239–245.
CrossRef +
Kimmel
CA, Young
JF Correlating pharmacokinetics and teratogenic endpoints. Fundam Appl Toxicol. 1983;3:250–255.
CrossRef +
Klaassen
CD, Lehman-McKeeman
LD Induction of metallothionein. J Am Coll Toxicol. 1989;8:1315–1321.
CrossRef +
Kleinstreuer
NC, Judson
RS, Reif
DM
et al Environmental impact on vascular development predicted by high-throughput screening. Environ Health Perspect. 2011;119:1596–1603.
CrossRef +
Kochhar
DM Teratogenic activity of retinoic acid. Acta Pathol Microbiol Scand. 1967;70:398–404.
CrossRef +
Knudsen
TB, Kleinstreuer
NC Disruption of embryonic vascular development in predictive toxicology. Birth Defects Res C Embryo Today. 2011;93:312–323.
CrossRef +
Knudsen
TB, Daston
GP Virtual tissues and developmental systems biology. In: McQueen CA, ed. Comprehensive Toxicology. 2nd ed., Vol 12. Daston GP, Knudsen TB, eds. Developmental Toxicology. New York: Elsevier; 2010:347–358.
+
Knudsen
TB, Martin
MT, Kavlock
RJ
et al Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA’s ToxRefDB. Reprod Toxicol. 2009;28:208–219.
+
Kola
I, Vogel
R, Spielmann
H Co-administration of ascorbic acid with cyclophosphamide (CPA) to pregnant mice inhibits the clastogenic activity of CPA in preimplantation murine blastocysts. Mutagenesis. 1989;4:297–301.
CrossRef +
Koopman-Esseboom
C, Weisglas-Kuperus
N, de Ridder
MAJ
et al Effects of polychlorinated biphenyl/dioxin exposure and feeding type on infants mental and psychomotor development. Pediatrics. 1996;97:700–706.
+
Koren
G, Nulman
I, Chudley
AE, Loocke
C Fetal alcohol spectrum disorder. CMAJ. 2003;169:1181–1185.
+
Kotch
LE, Sulik
KK Experimental fetal alcohol syndrome: proposed pathogenic basis for a variety of associated facial and brain anomalies. Am J Med Genet. 1992;44:168–176.
CrossRef +
Krauer
B Physiological changes and drug disposition during pregnancy. In: Nau H, Scott WJ, eds. Pharmacokinetics in Teratogenesis. Vol 1. Boca Raton, FL: CRC Press; 1987:3–12.
+
Krtolica
A, Ilic
D, Genbacev
O
et al Human embryonic stem cells as a model for embryotoxicity screening. Regen Med. 2009;4:449–459.
CrossRef +
Krumlauf
R
Hox genes and pattern formation in the branchial region of the vertebrate head. Trends Genet. 1993;9:106–112.
CrossRef +
Kyrklund-Blomberg
NB, Cnattingius
S Preterm birth and maternal smoking: risks related to gestational age and onset of delivery. Am J Obstet Gynecol. 1998;179:1051–1055.
CrossRef +
Lammer
EJ, Chen
DT, Hoar
RM
et al Retinoic acid induced embryopathy. N Engl J Med. 1985;313:837–841.
CrossRef +
Lammer
EJ, Sever
LE, Oakley
GP
Jr Teratogen update: valproic acid. Teratology. 1987;35:465–473.
CrossRef +
Lammer
EJ, Shaw
GM, Iovannisci
DM, Finnell
RH Maternal smoking, genetic variation of glutathione s-transferases, and risk for orofacial clefts. Epidemiology. 2005;16:698–701.
CrossRef +
Lammer
EJ Retinoids: interspecies comparisons and clinical results. In: Sundwall A, Danielsson BR, Hagberg O,
et al, eds. Developmental Toxicology—Preclinical and Clinical Data in Retrospect. Stockholm: Tryckgruppen; 1992:105–109.
+
Landrigan
PJ, Miodovnik
A Children’s health and the environment: an overview. Mt Sinai J Med. 2011;78:1–10.
CrossRef +
Lary
JM, Daniel
KL, Erickson
JD
et al The return of thalidomide: can birth defects be prevented? Drug Saf. 1999;21:161–169.
CrossRef +
Latham
KE Epigenetic modification and imprinting of the mammalian genome during development. Curr Top Dev Biol. 1999;43:1–49.
+
Lau
C, Butenhoff
JL, Rogers
JM The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol. 2004;198:231–241.
CrossRef +
Lau
C, Kavlock
RJ Functional toxicity in the developing heart, lung and kidney. In: Kimmel CA, Buelke-Sam J, eds. Developmental Toxicology. 2nd ed. New York: Raven Press; 1994:119–188.
+
Lau
C, Mole
ML, Copeland
MF
et al Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: acquisition of experimental data. Toxicol Sci. 2001;59:37–48.
CrossRef +
Lau
C, Rogers
JM Embryonic and fetal programming of physiological disorders in adulthood. Birth Defects Res C Embryo Today. 2004;72:300–312.
CrossRef +
Lau
C, Setzer
RW Biologically based risk assessment models for developmental toxicity. In: Tuan RS, Lo CW, eds. Developmental Biology Protocols. Vol II. Totowa, NJ: Humana Press; 2000:271–281.
+
Lavin
M, Watters
D eds. Programmed Cell Death: The Cellular and Molecular Biology of Apoptosis. Chur, Switzerland: Harwood Academic Publishers; 1993.
+
Lee
CJ, Goncalves
LL, Wells
PG Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)-dependent, reactive oxygen species (ROS)-mediated mechanism. FASEB J. 2011;25:2468–2483.
CrossRef +
Lee
HY, Inselman
AL, Kanungo
J
et al Alternative models in developmental toxicology. Syst Biol Reprod Med. 2012;58:10–22.
CrossRef +
Lenz
W Kindliche Missbildungen nach Medikament-Einnahme während der Gravidität? Dtsch Med Wochenschr. 1961;86:2555–2556.
+
Lenz
W Das thalidomid-syndrom. Fortschr Med. 1963;81:148–153.
+
Lenz
W A short history of thalidomide embryopathy. Teratology. 1988;38:203–215.
CrossRef +
Lenz
W, Knapp
K Die thalidomide-embryopathie. Dtsch Med Wochenschr. 1962;87:1232–1242.
CrossRef +
Leonardi-Bee
J, Britton
J, Venn
A Secondhand smoke and adverse fetal outcomes in nonsmoking pregnant women: a meta-analysis. Pediatrics. 2011;127:734–741.
CrossRef +
Leonardi-Bee
J, Smyth
A, Britton
J
et al Environmental tobacco smoke and fetal health: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2008;93:F351–F361.
CrossRef +
Levin
AA, Miller
RK Fetal toxicity of cadmium in the rat: maternal vs. fetal injections. Teratology. 1980;22:1–5.
CrossRef +
Li
Y, Sasaki
H Genomic imprinting in mammals: its life cycle, molecular mechanisms and reprogramming. Cell Res. 2011;21:466–473.
CrossRef +
Little
RE Moderate alcohol use during pregnancy and decreased infant birth weight. Am J Public Health. 1977;67:1154–1156.
CrossRef +
Little
SA, Mirkes
PE Relationship of DNA damage and embryotoxicity induced by 4-hydroperoxydichlorocyclophosphamide in postimplantation rat embryos. Teratology. 1990;41:223–231.
CrossRef +
Little
SA, Mirkes
PE Effects of 4-hydroperoxycyclophosphamide (4-OOH-CP) and 4-hydroperoxydichlorocyclophosphamide (4-OOH-deClCP) on the cell cycle of postimplantation rat embryos. Teratology. 1992;45:163–173.
CrossRef +
Lohnes
D, Mark
M, Mendelsohn
C
et al Function of the retinoic acid receptors (RARs) during development: I. Craniofacial and skeletal abnormalities in RAR double mutants. Development. 1994;120:2723–2748.
+
Love
DR, Pichler
FB, Dodd
A, Copp
BR, Greenwood
DR Technology for high-throughput screens: the present and future using zebrafish. Curr Opin Biotechnol. 2004;15:564–571.
CrossRef +
Luecke
RH, Wosilait
WD, Pearce
BA, Young
JF A physiologically based pharmacokinetic computer model for human pregnancy. Teratology. 1994;49:90–103.
CrossRef +
Luecke
RH, Wosilait
WD, Young
JF Mathematical analysis for teratogenic sensitivity. Teratology. 1997;55:373–380.
CrossRef +
Luecke
RH, Wosilait
WD, Young
JF Mathematical modeling of human embryonic and fetal growth rates. Growth Dev Aging. 1999;63:49–59.
+
Luijten
M, van Beelen
VA, Verhoef
A
et al Transcriptomics analysis of retinoic acid embryotoxicity in rat postimplantation whole embryo culture. Reprod Toxicol. 2010;30:333–340.
CrossRef +
Lutiger
B, Graham
K, Einarson
TR, Koren
G Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis. Teratology. 1991;44:405–414.
CrossRef +
Mably
TA, Bjerke
DL, Moore
RW
et al In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 3. Effects on spermatogenesis and reproductive capability. Toxicol Appl Pharmacol. 1992;114:118–126.
CrossRef +
MacAuley
AM, Werb
Z, Mirkes
PE Characterization of the unusually rapid cell cycles during rat gastrulation. Development. 1993;117:873–883.
+
MacDonald
H, Tobin
JOH Congenital cytomegalovirus infection: a collaborative study on epidemiological, clinical and laboratory findings. Dev Med Child Neurol. 1978;20:271–282.
+
Mallo
M, Wellik
DM, Deschamps
J Hox genes and regional patterning of the vertebrate body plan. Dev Biol. 2010;344:7–15.
CrossRef +
Manning
MA, Hoyme
EH Fetal alcohol spectrum disorders: a practical clinical approach to diagnosis. Neurosci Biobehav Rev. 2007;31:230–238.
CrossRef +
Manson
JM Testing of pharmaceutical agents for reproductive toxicity. In: Kimmel CA, Buelke-Sam J, eds. Developmental Toxicology. 2nd ed. New York: Raven Press; 1994:379–402.
+
Maritz
GS, Harding
R Life-long programming implications of exposure to tobacco smoking and nicotine before and soon after birth: evidence for altered lung development. Int J Environ Res Public Health. 2011;8:875–898.
CrossRef +
Mark
M, Ghyselinck
NB, Chambon
P Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol. 2006;46:451–480.
CrossRef +
Mark
M, Ghyselinck
NB, Chambon
P Function of retinoic acid receptors during embryonic development. Nucl Recept Signal. 2009;7:e002.
+
Markert
CL, Petters
RM Manufactured hexaparental mice show that adults are derived from three embryonic cells. Science. 1978;202:56–58.
CrossRef +
Markussen Linnet
K, Obel
C, Bonde
E
et al Cigarette smoking during pregnancy and hyperactive-distractible preschoolers: a follow-up study. Acta Paediatr. 2006;95:694–700.
CrossRef +
Marshall
H, Morrison
A, Studer
M
et al Retinoids and hox genes. FASEB J. 1996;10:969–978.
+
Marshall
H, Nonchev
S, Sham
MH
et al Retinoic acid alters hindbrain Hox code and induces transformation of rhombomeres 2/3 into a 4/5 identity. Nature. 1992;360:737–741.
CrossRef +
Matalon
S, Schechtman
S, Goldzweig
G
et al The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol. 2002;16:9–17.
CrossRef +
Mattison
DR, Blann
E, Malek
A Physiological alterations during pregnancy: impact on toxicokinetics. Fundam Appl Toxicol. 1991;16:215–218.
CrossRef +
McBride
WG Thalidomide and congenital anomalies. Lancet. 1961;2:1358.
CrossRef +
McCollum
CW, Ducharme
NA, Bondesson
M, Gustafsson
J-A Developmental toxicity screening in zebrafish. Birth Defects Res C Embryo Today. 2011;93:67–114.
CrossRef +
McMillen
IC, Robinson
JS Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev. 2005;85:571–633.
CrossRef +
Medlock
KL, Branham
WS, Sheehan
DM Effects of coumestrol and equol on the developing reproductive tract of the rat. Proc Soc Exp Biol Med. 1995;208:67–71.
CrossRef +
Mendelsohn
C, Lohnes
D, Décimo
D
et al Function of the retinoic acid receptors (RARs) during development: II. Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development. 1994;120:2749–2771.
+
Menegola
E, Di Renzo
F, Broccia
ML
et al Inhibition of histone deacetylase as a new mechanism of teratogenesis. Birth Defects Res C Embryo Today. 2006;78:345–353.
CrossRef +
Mikkola
HK, Orkin
SH Gene targeting and transgenic strategies for the analysis of hematopoietic development in the mouse. Methods Mol Med. 2005;105:3–22.
+
Miller
MT, Stromland
K Teratogen update: thalidomide: a review with a focus on ocular findings and new potential uses. Teratology. 1999;60:306–321.
CrossRef +
Millicovsky
G, DeSesso
JM, Kleinman
LI, Clark
KE Effects of hydroxyurea on hemodynamics of pregnant rabbits: a maternally mediated mechanism of embryotoxicity. Am J Obstet Gynecol. 1981;140:747–752.
+
Millicovsky
G, DeSesso
JM Cardiovascular alterations in rabbit embryos in situ after a teratogenic dose of hydroxyurea: an in vivo microscopic study. Teratology. 1980a;22:115–124.
CrossRef +
Millicovsky
G, DeSesso
JM Differential embryonic cardiovascular responses to acute maternal uterine ischemia: an in vivo microscopic study of rabbit embryos with either intact or clamped umbilical cords. Teratology. 1980b;22:335–343.
CrossRef +
Millicovsky
G, Johnston
MC Maternal hyperoxia greatly reduces the incidence of phenytoin-induced cleft lip and palate in A/J mice. Science. 1981;212:671–672.
CrossRef +
Mills
JL, Signore
C Neural tube defect rates before and after food fortification with folic acid. Birth Defects Res A Clin Mol Teratol. 2004;70:844–845.
CrossRef +
Milunsky
A, Ulcickas
M, Rothman
KJ
et al Maternal heat exposure and neural tube defects. JAMA. 1992;268:882–885.
CrossRef +
Miodovnik
A Environmental neurotoxicants and developing brain. Mt Sinai J Med. 2011;78:58–77.
CrossRef +
Mirkes
PE, Fantel
AG, Greenaway
JC, Shepard
TH Teratogenicity of cyclophosphamide metabolites: phosphoramide mustard, acrolein, and 4-ketocyclophosphamide on rat embryos cultured in vitro. Toxicol Appl Pharmacol. 1981;58:322–330.
CrossRef +
Mirkes
PE, Greenaway
JC, Hilton
J, Brundrett
R Morphological and biochemical aspects of monofunctional phosphoramide mustard teratogenicity in rat embryos cultured in vitro. Teratology. 1985;32:241–249.
CrossRef +
Mirkes
PE, Ricks
JL, Pascoe-Mason
JM Cell cycle analysis in the cardiac and neuroepithelial tissues of day 10 rat embryos and the effects of phosphoramide mustard, the major teratogenic metabolite of cyclophosphamide. Teratology. 1989;39:115–120.
CrossRef +
Mirkes
PE Cyclophosphamide teratogenesis: a review. Teratogenicity Carcinog Mutagen. 1985a;5:75–88.
CrossRef +
Mirkes
PE Molecular and metabolic aspects of cyclophosphamide teratogenesis. In: Welsch F, ed. Approaches to Elucidate Mechanisms in Teratogenesis. Washington, DC: Hemisphere; 1987:123–147.
+
Mirkes
PE Simultaneous banding of rat embryo DNA, RNA and protein in cesium trifluoroacetate gradients. Anal Biochem. 1985b;148:376–383.
CrossRef +
Mitchell
EA, Milerad
J Smoking and the sudden infant death syndrome. Rev Environ Health. 2006;21:81–103.
CrossRef +
Mitra
SC Effects of cocaine on fetal kidney and bladder function. J Maternal Fetal Med. 1999;8:262–269.
+
Montgomery
SM, Ekbom
A Smoking during pregnancy and diabetes mellitus in a British longitudinal birth cohort. BMJ. 2002;324:26–27.
CrossRef +
Moore
NW, Adams
CE, Rowson
LEA Developmental potential of single blastomeres of the rabbit egg. J Reprod Fertil. 1968;17:527–531.
CrossRef +
Mouritsen
A, Aksglaede
L, Sørensen
K
et al Hypothesis: exposure to endocrine-disrupting chemicals may interfere with timing of puberty. Int J Androl. 2010;33:346–359.
CrossRef +
Frost
C, Stone
R; MRC Vitamin Study Research Group [prepared by Wald N with assistance from Sneddon J. Prevention of neural tube defects: results of the MRC vitamin study. Lancet. 1991;338:132–137.
+
Murphy
SK, Jirtle
RL Imprinted genes as potential genetic and epigenetic toxicologic targets. Environ Health Perspect. 2000;108(suppl 1):5–11.
CrossRef +
Myatt
L Placental adaptive responses and fetal programming. J Physiol. 2006;572:25–30.
+
Mylchreest
E, Cattley
RC, Foster
PM Male reproductive tract malformations in rats following gestational and lactational exposure to di(n-butyl)phthalate: an anti-androgenic mechanism? Toxicol Sci. 1998;43:47–60.
CrossRef +
Mylchreest
E, Sar
M, Cattley
RC, Foster
PM Disruption of androgen-regulated male reproductive development by di(
n-butyl)phthalate during late gestation in rats is different from flutamide. Toxicol Appl Pharmacol. 1999;156:81–95.
CrossRef +
Naciff
JM, Hess
KA, Overmann
GJ
et al Gene expression changes induced in the testis by transplacental exposure to high and low doses of 17{alpha}-ethynyl estradio, genistein, or bisphenol A. Toxicol Sci. 2005;86:396–416.
CrossRef +
Nagel
SC, vom Saal
FS, Thayer
KA
et al Relative binding affinity–serum modified access (RBA–SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect. 1997;105:70–76.
CrossRef +
National Research Council. Pesticides in the Diets of Infants and Children. Washington, DC: National Academy Press; 1993.
+
National Research Council. Scientific Fromtiers in Developmental Toxicology and Risk Assessment. Washington, DC: National Academy Press; 2000.
+
National Research Council. Toxicity Testing in the Twenty-FirstCentury: A Vision and a Strategy. Washington, DC: National Academies Press; 2007.
+
Nau
H Species differences in pharmacokinetics and drug teratogenesis. Environ Health Perspect. 1986;70:113–129.
CrossRef +
Nau
H Physicochemical and structural properties regulating placenta drug transfer. In: Polin RA, Fox WW, eds. Fetal and Neonatal Physiology. Vol 1. Philadelphia: Saunders; 1992:130–149.
+
Nau
H, Chahoud
I, Dencker
L
et al Teratogenicity of vitamin A and retinoids. In: Blomhoff R, ed. Vitamin A in Health and Disease. New York: Marcel Dekker; 1994:615–664.
+
Nau
H, Hauck
R-S, Ehlers
K Valproic acid induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms. Pharmacol Toxicol. 1991;69:310–321.
CrossRef +
Nau
H, Helge
H, Luck
W Valproic acid in the perinatal period: decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and some metabolites. J Pediatr. 1984;104:627–634.
CrossRef +
Nau
H, Scott
WJ Weak acids may act as teratogens by accumulating in the basic milieu of the early mammalian embryo. Nature. 1986;323:276–278.
CrossRef +
Nau
H, Scott
WJ Pharmacokinetics in Teratogenesis. Vols I and II. Boca Raton, FL: CRC Press; 1987.
+
Nawrot
PS, Cook
RO, Hamm
CW Embryotoxicity of broadband high-frequency noise in the CD-1 mouse. J Toxicol Environ Health. 1981;8:151–157.
CrossRef +
Nawrot
PS, Cook
RO, Staples
RE Embryotoxicity of various noise stimuli in the mouse. Teratology. 1980;22:279–289.
CrossRef +
Needham
LL, Ozkaynak
H, Whyatt
RM
et al Exposure assessment in the National Children’s Study: introduction. Environ Health Perspect. 2005;113:1076–1082.
CrossRef +
Neims
AH, Warner
M, Loughnan
PM, Aranda
JV Developmental aspects of the hepatic cytochrome P
450 monooxygenase system. Annu Rev Pharmacol Toxicol. 1976;16:427–444.
CrossRef +
Nelson
CJ, Holson
JF Statistical analysis of teratologic data: problems and recent advances. J Environ Pathol Toxicol. 1978;2:187–199.
+
Neubert
D In-vitro techniques for assessing teratogenic potential. In: Dayan AD, Paine AJ, eds. Advances in Applied Toxicology. London: Taylor and Francis; 1989:191–211.
+
Neubert
R, Hinz
N, Thiel
R, Neubert
D Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomide. Life Sci. 1996;58:295–316.
CrossRef +
Neubert
R, Neubert
D Peculiarities and possible mode of actions of thalidomide. In: Kavlock RJ, Daston GP, eds. Drug Toxicity in Embryonic Development, II. Berlin, Heidelberg: Springer-Verlag; 1997:41–119.
+
Neubert
D, Zens
P, Rothenwallner
A, Merker
H-J A survey of the embryotoxic effects of TCDD in mammalian species. Environ Health Perspect. 1973;5:63–79.
CrossRef +
New DAT. Whole embryo culture and the study of mammalian embryos during organogenesis. Biol Rev. 1978;5:81–94.
+
Newbold
RR, Padilla-Banks
E, Jefferson
WN Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology. 2006;147:S11–S17.
CrossRef +
Newbold
RR, Padilla-Banks
E, Jefferson
WN Environmental estrogens and obesity. Mol Cell Endocrinol. 2009;304:84–89.
CrossRef +
Newbold
RR Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ Health Perspect. 1995;103(suppl 7):83–87.
CrossRef +
Newman
CGH Teratogen update: clinical aspects of thalidomide embryopathy—a continuing preoccupation. Teratology. 1985;32:133–144.
CrossRef +
Nicol
CJ, Harrison
ML, Laposa
RR, Gimelshtein
IL, Wells
PG A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nat Genet. 1995;10:181–187.
CrossRef +
Nowack
E The sensitive phase in thalidomide embryopathy. Humangenetik. 1965;1:516–536.
CrossRef +
Nugent
P, Sucov
HM, Pisano
MM, Greene
RM The role of RXR-alpha in retinoic acid–induced cleft palate as assessed with the RXR-alpha knockout mouse. Int J Dev Biol. 1999;43:567–570.
+
O’Flaherty
EJ, Scott
WJ, Shreiner
C, Beliles
RP A physiologically based kinetic model of rat and mouse gestation: disposition of a weak acid. Toxicol Appl Pharmacol. 1992;112:245–256.
CrossRef +
O’Flaherty
EJ Pharmacokinetics, pharmacodynamics, and prediction of developmental abnormalities. Reprod Toxicol. 1997;11:413–416.
CrossRef +
Okada
A, Aoki
Y, Kushima
K, Kurihara
H, Bialer
M, Fujiwara
M Polycomb homologs are involved in teratogenicity of valproic acid in mice. Birth Defects Res A Clin Mol Teratol. 2004;70:870–879.
CrossRef +
Okada
A, Kushima
K, Aoki
Y, Bialer
M, Fujiwara
M Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice. Birth Defects Res A Clin Mol Teratol. 2005;73:229–238.
CrossRef +
Oken
E, Levitan
EB, Gillman
MW Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis. Int J Obes (Lond). 2008;32:201–210.
CrossRef +
Olanoff
LS, Anderson
JM Controlled release of tetracycline—III: a physiological pharmacokinetic model of the pregnant rat. J Pharmacokinet Biopharm. 1980;8:599–620.
CrossRef +
Olsen
GW, Bodner
KM, Ramlow
JM, Ross
CE, Lipshultz
LI Have sperm counts been reduced 50 percent in 50 years? A statistical model revisited. Fertility and Sterility. 1995;63:887–893.
+
Oltvai
ZN, Korsmeyer
SJ Checkpoints of dueling dimers foil death wishes. Cell. 1994;79:189–192.
CrossRef +
Ornoy
A Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. Reprod Toxicol. 2006;22:214–226.
CrossRef +
Ostrea
E
Jr, Matias
O, Keane
C
et al Spectrum of gestational exposure to illicit drugs and other xenobiotic agents in newborn infants meconium analysis. J Pediatr. 1998;133:513–515.
CrossRef +
Ozolins
TR Cyclophosphamide and the Teratology Society: an awkward marriage. Birth Defects Res B Dev Reprod Toxicol. 2010;89:289–299.
CrossRef +
Padilla
S, Corum
D, Padnos
B
et al Zebrafish developmental screening of the ToxCast Phase I chemical library. Reprod Toxicol. 2012;33:174–187.
CrossRef +
Page
K, Abramovich
D, Aggett
P
et al Uptake of zinc by the human placenta microvillus border membranes and characterization of the effects of cadmium on the process. Placenta. 1992;13:151–162.
CrossRef +
Paladini
D, Vassallo
M, D’Armiento
MR
et al Prenatal detection of multiple fetal anomalies following inadvertent exposure to cyclophosphamide in the first trimester of pregnancy. Birth Defects Res A Clin Mol Teratol. 2004;70:99–100.
CrossRef +
Parizek
J Vascular changes at sites of estrogen biosynthesis produced by parenteral injection of cadmium salts: the destruction of the placenta by cadmium salts. J Reprod Fertil. 1964;7:263–265.
CrossRef +
Park
D, Yang
YH, Choi
EK
et al Licorice extract increases cyclophosphamide teratogenicity by upregulating the expression of cytochrome P-450 2B mRNA. Birth Defects Res B Dev Reprod Toxicol. 2011;92:553–559.
CrossRef +
Parman
T, Wiley
MJ, Wells
PG Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity. Nat Med. 1999;5:582–585.
CrossRef +
Paulozzi
LJ, Erickson
JD, Jackson
RJ Hypospadias trends in two American surveillance systems. Pediatrics. 1997;100:831–834.
CrossRef +
Paulozzi
LJ International trends in rates of hypospadias and cryptorchidism. Environ Health Perspect. 1999;107:297–302.
CrossRef +
Perera
F, Herbstman
J Prenatal environmental exposures, epigenetics, and disease. Reprod Toxicol. 2011;31:363–373.
CrossRef +
Piersma
AH, Genschow
E, Verhoef
A
et al Validation of the postimplantation rat whole-embryo culture test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim. 2004;32:275–307.
+
Piersma
AH, Hernandez
LG, van Benthem
J
et al Reproductive toxicants have a threshold of adversity. Crit Rev Toxicol. 2011a;41:545–554.
CrossRef +
Piersma
AH, Rorije
E, Beekhuijzen
ME
et al Combined retrospective analysis of 498 rat multi-generation reproductive toxicity studies: on the impact of parameters related to F1 mating and F2 offspring. Reprod Toxicol. 2011b;31:392–401.
CrossRef +
Piersma
AH, van Dartel
DAM, van der Ven
LTM Alternative methods in developmental toxicology. In: McQueen CA, ed. Comprehensive Toxicology. 2nd ed., Vol 12. Daston GP, Knudsen TB, eds. Developmental Toxicology. New York: Elsevier; 2010:293–305.
+
Pinkerton
KE, Joad
JP The mammalian respiratory system and critical windows of exposure for children’s health. Environ Health Perspect. 2000;108(suppl 3):457–462.
CrossRef +
Pole
M, Einarson
A, Pairaudeau
N
et al Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionals. J Clin Pharmacol. 2000;40:573–577.
CrossRef +
Poskanzer
D, Herbst
AL Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero. Cancer. 1977;39:1892–1895.
CrossRef +
Potter
SM, Zelazo
PR, Stack
DM, Papageorgiou
AN Adverse effects of fetal cocaine exposure on neonatal auditory information processing. Pediatrics. 2000;105:E40.
CrossRef +
Quan
A Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev. 2006;82:23–28.
CrossRef +
Registration, Evaluation, Authorisation and Restriction of Chemicals. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Official Journal of the European Union L. 2006;396:1–849.
http://home.kpn.nl/reach/downloads/reachtestingneedsfinal.pdf. Accessed on May 11, 2011.
+
Reuter
U, Heinrich-Hirsch
B, Hellwig
J, Holzum
B, Welsch
F Evaluation of OECD screening tests 421 (reproduction/developmental toxicity screening test) and 422 (combined repeated dose toxicity study with the reproduction/developmental toxicity screening test). Regul Toxicol Pharmacol. 2003;38:17–26.
CrossRef +
Rider
CV, Furr
JR, Wilson
VS
et al Cumulative effects of in utero administration of mixtures of reproductive toxicants that disrupt common target tissues via diverse mechanisms of toxicity. Int J Androl. 2010;33:443–462.
CrossRef +
Rider
CV, Wilson
VS, Howdeshell
KL
et al Cumulative effects of in utero administration of mixtures of “antiandrogens” on male rat reproductive development. Toxicol Pathol. 2009;37:100–113.
CrossRef +
Robertson
J, Polifka
JE, Avner
M
et al A survey of pregnant women using isotretinoin. Birth Defects Res A Clin Mol Teratol. 2005;73:881–887.
CrossRef +
Robinson
JF, Pennings
JL, Piersma
AH A review of toxicogenomic approaches in developmental toxicology. Methods Mol Biol. 2012a;889:347–371.
+
Robinson
JF, Theunissen
PT, van Dartel
DA
et al Comparison of MeHg-induced toxicogenomic responses across in vivo and in vitro models used in developmental toxicology. Reprod Toxicol. 2011a;32:180–188.
CrossRef +
Robinson
JF, Tonk
EC, Verhoef
A, Piersma
AH Triazole induced concentration-related gene signatures in rat whole embryo culture. Reprod Toxicol. 2012b;34:275–283.
CrossRef +
Robinson
JF, van Beelen
VA, Verhoef
A
et al Embryotoxicant-specific transcriptomic responses in rat postimplantation whole-embryo culture. Toxicol Sci. 2010;118:675–685.
CrossRef +
Robinson
JF, Verhoef
A, Pennings
JL
et al A comparison of gene expression responses in rat whole embryo culture and in vivo: time-dependent retinoic acid-induced teratogenic response. Toxicol Sci. 2012c;126:242–254.
CrossRef +
Robinson
JF, Verhoef
A, Piersma
AH Transcriptomic analysis of neurulation and early organogenesis in rat embryos: an in vivo and ex vivo comparison. Toxicol Sci. 2012d;126:255–266.
CrossRef +
Robinson
JF, Yu
X, Moreira
EG
et al Arsenic- and cadmium-induced toxicogenomic response in mouse embryos undergoing neurulation. Toxicol Appl Pharmacol. 2011b;250:117–129.
CrossRef +
Rodier
PM, Cohen
IR, Buelke-Sam
J Developmental neurotoxicology: neuroendocrine manifestations of CNS insult. In: Kimmel CA, Buelke-Sam J, eds. Developmental Toxicology. 2nd ed. New York: Raven Press; 1994:65–92.
+
Rogan
WJ, Gladen
BC PCBs, DDE and child development at 18 and 24 months. Am J Epidemiol. 1991;1:407–413.
+
Rogers
JM Tobacco and pregnancy: overview of exposures and effects. Birth Defects Res C Embryo Today. 2008;84:1–15.
CrossRef +
Rogers
JM, Chernoff
N, Keen
CL, Daston
GP Evaluation and interpretation of maternal toxicity in Segment II studies: issues, some answers, and data needs. Toxicol Appl Pharmacol. 2005;207:367–374.
CrossRef +
Rogers
JM, Ellis-Hutchings
RG, Lau
C Epigenetics and the developmental origins of health and disease. In: McQueen CA, ed. Comprehensive Toxicology. 2nd ed., Vol 12. Daston GP, Knudsen TB, eds. Developmental Toxicology. New York: Elsevier; 2010:69–88.
+
Rogers
JM, Mole
ML Critical periods of sensitivity to the developmental toxicity of inhaled methanol in the CD-1 mouse. Teratology. 1997;55:364–372.
CrossRef +
Rosa
FW Teratogenicity of isotretinoin. Lancet. 1983;2:513.
CrossRef +
Rosa
FW Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med. 1991;324:674–677.
CrossRef +
Rosen
MB, Schmid
JE, Das
KP
et al Gene expression profiling in the liver and lung of perfluorooctane sulfonate-exposed mouse fetuses: comparison to changes induced by exposure to perfluorooctanoic acid. Reprod Toxicol. 2009;27:278–288.
CrossRef +
Rosen
MB, Schmid
JR, Corton
JC
et al Gene expression profiling in wild-type and PPAR-alpha-null mice exposed to perfluorooctane sulfonate reveals PPAR-alpha-independent effects. PPAR Res. 2010; 2010:23.
CrossRef +
Rosen
MB, Thibodeaux
JR, Wood
CR
et al Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses. Toxicology. 2007;239:15–33.
CrossRef +
Rovida
C, Longo
F, Rabbit
RR How are reproductive toxicity and developmental toxicity addressed in REACH dossiers? ALTEX. 2011;28:273–294.
CrossRef +
Rozman
KK, Bhatia
J, Calafat
AM
et al NTP-CERHR expert panel report on the reproductive and developmental toxicity of soy formula. Birth Defects Res B Dev Reprod Toxicol. 2006;77:280–397.
CrossRef +
Rutledge
JC, Shourbaji
AG, Hughes
LA
et al Limb and lower-body duplications induced by retinoic acid in mice. Proc Natl Acad Sci U S A. 1994;91:5436–5440.
CrossRef +
Sadler
TW, Warner
CW Use of whole embryo culture for evaluating toxicity and teratogenicity. Pharmacol Rev. 1984;36:145S–150S.
+
Sanes
JR, Rubenstein
LR, Nicolas
JF Use of a recombinant retrovirus to study postimplantation cell lineage in mouse embryos. EMBO J. 1986;5:3133–3142.
+
Sannerstedt
R, Lundborg
P, Danielsson
BR
et al Drugs during pregnancy: An issue of risk classification and information to prescribers. Drug Saf. 1996;14:69–77.
CrossRef +
Sanyal
MK, Kitchin
KT, Dixon
RL Anomalous development of rat embryos cultured in vitro with cyclophosphamide and microsomes. Pharmacologist. 1979;21:A231.
+
Sasaki
H, Matsui
Y Epigenetic events in mammalian germ-cell development: reprogramming and beyond. Nat Rev Genet. 2008;9:129–140.
CrossRef +
Sauer
H, Gunther
J, Hescheler
J, Wartenberg
M Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals. Am J Pathol. 2000;56:151–158.
CrossRef +
Saydmohammed
M, Vollmer
LL, Onuoha
EO
et al A high-content screening assay in transgenic zebrafish identifies two novel activators of fgf signaling. Birth Defects Res C Embryo Today. 2011;93:281–287.
CrossRef +
Scanlon
JW The neuroteratology of cocaine: background, theory, and clinical implications. Reprod Toxicol. 1991;5:89–98.
CrossRef +
Schaefer
C Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity. Birth Defects Res A Clin Mol Teratol. 2003;67:591–594.
CrossRef +
Schantz
SL, Levin
ED, Bowman
RE Long-term neurobehavioral effects of perinatal PCB exposure in monkeys. J Environ Toxicol Chem. 1991;10:747–756.
CrossRef +
Schantz
SL, Moshtaghian
J, Ness
DK Spatial learning deficits in adult rats exposed to ortho-substituted PCB congeners during gestation and lactation. Fundam Appl Toxicol. 1995;26:117–126.
CrossRef +
Schardein
JL Chemically Induced Birth Defects. 2nd ed. New York: Marcel Dekker; 1993.
+
Schardein
JL Chemically Induced Birth Defects. 3nd ed. New York: Marcel Dekker; 2000.
+
Schardein
JL, Keller
KA Potential human developmental toxicants and the role of animal testing in their identification and characterization. CRC Crit Rev Toxicol. 1989;19:251–339.
CrossRef +
Schardein
JL, Macina
OT Human Developmental Toxicants: Aspects of Toxicology and Chemistry. Boca Raton, FL: CRC Press, Taylor and Francis Group; 2007;427.
+
Schecter
A, Ryan
JJ, Masuda
Y
et al Chlorinated and brominated dioxins and dibenzofurans in human tissue following exposure. Environ Health Perspect. 1994;102(suppl 1):135–147.
CrossRef +
Schumacher
HJ Chemical structure and teratogenic properties. In: Shepard T, Miller R, Marois M, eds. Methods for Detection of Environmental Agents That Produce Congenital Defects. New York: American Elsevier; 1975:65–77.
+
Schwab
C, Jagannath
S The role of thalidomide in multiple myeloma. Clin Lymphoma Myeloma. 2006;7:26–29.
CrossRef +
Scialli
AR The challenge of reproductive and developmental toxicology under REACH. Regul Toxicol Pharmacol. 2008;51:244–250.
CrossRef +
Seckl
JR, Holmes
MC Mechanisms of disease: glucocorticoids, their placental metabolism and fetal ‘programming’ of adult pathophysiology. Nat Clin Pract Endocrinol Metab. 2007;3:479–488.
CrossRef +
Seiler
A, Visan
A, Buesen
R, Genschow
E, Spielmann
H Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test. Reprod Toxicol. 2004;18:231–240.
CrossRef +
Selderslaghs
IWT, Blust
R, Witters
HE Feasibility study of the zebrafish assay as an alternative method to screen for developmental toxicity and embryotoxicity using a training set of 27 compounds. Reprod Toxicol. 2012;33:142–154.
CrossRef +
Seller
MJ, Perkins
KJ, Adinolfi
M Differential response of heterozygous curly-tail mouse embryos to vitamin A teratogenesis depending on maternal genotype. Teratology. 1983;28:123.
CrossRef +
Setzer
RW, Lau
C, Mole
ML, Copeland
MF, Rogers
JM, Kavlock
RJ Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: a mathematical construct. Toxicol Sci. 2001;59:49–58.
CrossRef +
Sever
JL Rubella as a teratogen. Adv Teratol. 1967;2:127–138.
+
Shan
G RNA interference as a gene knockdown technique. Int J Biochem Cell Biol. 2010;42:1243–1251.
CrossRef +
Shenefelt
RE Morphogenesis of malformations in hamsters caused by retinoic acid: Relation to dose and stage of treatment. Teratology. 1972;5:103–118.
CrossRef +
Shepard
TH, Lemire
RJ Catalog of Teratogenic Agents. 11th ed. Baltimore: The Johns Hopkins University Press; 2004.
+
Shi
M, Wehby
GL, Murray
JC Review on genetic variants and maternal smoking in the etiology of oral clefts and other birth defects. Birth Defects Res C Embryo Today. 2008;84:16–29.
CrossRef +
Shuey
DL, Lau
C, Logsdon
TR
et al Biologically based dose–response modeling in developmental toxicology: biochemical and cellular sequelae of 5-fluorouracil exposure in the developing rat. Toxicol Appl Pharmacol. 1994;126:129–144.
CrossRef +
Sipes
NS, Martin
MT, Reif
DM
et al Predictive models of prenatal developmental toxicity from ToxCast high-throughput screening data. Toxicol Sci. 2011a;124:109–127.
CrossRef +
Sipes
NS, Padilla
S, Knudsen
TB Zebrafish: as an integrative model for twenty-first century toxicity testing. Birth Defects Res C Embryo Today. 2011b;93:256–267.
CrossRef +
Skakkebaek
NE, Keiding
N Changes in semen and the testis. Br Med J. 1994;309:1316–1317.
CrossRef +
Skinner
MK, Manikkam
M, Guerrero-Bosagna
C Epigenetic transgenerational actions of endocrine disruptors. Reprod Toxicol. 2011;31:337–343.
CrossRef +
Slikker
W
Jr, Xu
ZA, Levin
ED, Slotkin
TA Mode of action: disruption of brain cell replication, second messenger, and neurotransmitter systems during development leading to cognitive dysfunction—developmental neurotoxicity of nicotine. Crit Rev Toxicol. 2005;35:703–711.
CrossRef +
Slikker
W, Miller
RK Placental metabolism and transfer: role in developmental toxicology. In: Kimmel CA, Buelke-Sam J, eds. Developmental Toxicology. 2nd ed. New York: Raven Press; 1994:245–283.
+
Slotkin
TA Fetal nicotine or cocaine exposure: which one is worse? J Pharmacol Exp Ther. 1998;285:931–945.
+
Slott
VL, Hales
BF Sodium 2-mercaptoethane sulfonate protection against cyclophosphamide-induced teratogenicity in rats. Toxicol Appl Pharmacol. 1986;82:80–86.
CrossRef +
Smith
SM Alcohol and cell death. In: McQueen CA, ed. Comprehensive Toxicology. 2nd ed., Vol 12. Daston GP, Knudsen TB, eds. Developmental Toxicology. New York: Elsevier; 2010:223–238.
+
Smith
JL, Gesteland
KM, Schoenwolf
GC Prospective fate map of the mouse primitive streak at 7.5 days of gestation. Dev Dynam. 1994;201:279–289.
CrossRef +
Snow
MHL, Tam
PPL Is compensatory growth a complicating factor in mouse teratology? Nature. 1979;279:555–557.
CrossRef +
Sokol
RJ, Delaney-Black
V, Nordstrom
B Fetal alcohol spectrum disorder. JAMA. 2003;290:2996–2999.
CrossRef +
Sorrell
TL, Graziano
JH Effect of oral cadmium exposure during pregnancy on maternal and fetal zinc metabolism in the rat. Toxicol Appl Pharmacol. 1990;102:537–545.
CrossRef +
Spielmann
H, Genschow
E, Brown
NA
et al Validation of the rat limb bud micromass test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim. 2004;32:245–274.
+
Stephens
TD Proposed mechanisms of action in thalidomide embryopathy. Teratology. 1988;38:229–239.
CrossRef +
Stephens
TD, Bunde
CJ, Fillmore
BJ Mechanism of action in thalidomide teratogenesis. Biochem Pharmacol. 2000;59:1489–1499.
CrossRef +
Stephens
TD, Bunde
CJW, Torres
RD
et al Thalidomide inhibits limb development throught its antagonism of IFG-I+FGF-2+heparin (abstr). Teratology. 1998;57:112.
+
Stephens
TD, Fillmore
BJ Hypothesis: thalidomide embryopathy: proposed mechanism of action. Teratology. 2000;61:189–195.
CrossRef +
Stirling
DI, Sherman
M, Strauss
S Thalidomide: a surprising recovery. J Am Pharmacol Assoc. 1997;NS37:307–313.
+
Stockard
CR Developmental rate and structural expression: an experimental study of twins, “double monsters,” and single deformities, and the interaction among embryonic organs during their origin and development. Am J Anat. 1921;28:115–277.
CrossRef +
Stott
DH Follow-up study from birth of the effects of prenatal stress. Dev Med Child Neurol. 1973;15:770–787.
CrossRef +
Streissguth
AP, Aase
JM, Clarren
SK
et al Fetal alcohol syndrome in adolescents and adults. JAMA. 1991a;265:1961–1967.
CrossRef +
Streissguth
AP, Barr
HM, Olson
HC
et al Drinking during pregnancy decreases word attack and arithmetic scores on standardized tests: adolescent data from a population-based prospective study. Alcohol Clin Exp Res. 1994a;18:248–254.
CrossRef +
Streissguth
AP, Randels
SP, Smith
DF A test-retest study of intelligence in patients with fetal alcohol syndrome: implications for care. J Am Acad Child Adolesc Psychiatry. 1991b;30:584–587.
CrossRef +
Streissguth
AP, Sampson
PD, Olson
HC
et al Maternal drinking during pregnancy: attention and short-term memory in 14-year-old offspring: a longitudinal prospective study. Alcohol Clin Exp Res. 1994b;18:202–218.
CrossRef +
Struve
MF, Gaido
KW, Hensley
JB
et al Reproductive toxicity and pharmacokinetics of di-n-butyl phthalate (DBP) following dietary exposure of pregnant rats. Birth Defects Res B Dev Reprod Toxicol. 2009;86:345–354.
CrossRef +
Sulik
KK Genesis of alcohol-induced craniofacial dysmorphism. Exp Biol Med. 2005;230:366–375.
+
Sulik
KK, Johnston
MC Sequence of developmental alterations following acute ethanol exposure in mice: craniofacial features of the fetal alcohol syndrome. Am J Anat. 1983;166:257–269.
CrossRef +
Sulik
KK, Johnston
MC, Webb
MA Fetal alcohol syndrome: embryogenesis in a mouse model. Science. 1981;214:936–968.
CrossRef +
Suzuki
K, Ando
D, Sato
M
et al The association between maternal smoking during pregnancy and childhood obesity persists to the age of 9-10 years. J Epidemiol. 2009;19:136–142.
CrossRef +
Swann
SH, Elkin
EP, Fenster
L Have sperm counts declined? A reanalysis of global trend data. Environ Health Perspect. 1997;105:1228–1232.
CrossRef +
Tabacova
S Mode of action: angiotensin-converting enzyme inhibition—developmental effects associated with exposure to ACE inhibitors. Crit Rev Toxicol. 2005;35:747–755.
CrossRef +
Takeuchi
IK Teratogenic effects of methylnitrosourea on pregnant mice before implantation. Experientia. 1984;40:879–881.
CrossRef +
Tatum
WO Use of antiepileptic drugs in pregnancy. Expert Rev Neurother. 2006;6:1077–1086.
CrossRef +
Taubeneck
MW, Daston
GP, Rogers
JM, Keen
CL Altered maternal zinc metabolism following exposure to diverse developmental toxicants. Reprod Toxicol. 1994;8:25–40.
CrossRef +
Taussig
HB A study of the German outbreak of phocomelia: the thalidomide syndrome. JAMA. 1962;180:1106.
CrossRef +
Teratology Society. FDA classification system of drugs for teratogenic risk. Teratology. 1994;49:446–447.
CrossRef +
Terry
KK, Elswick
BA, Welsch
F
et al Development of a physiologically based pharmacokinetic model describing 2-methoxyacetic acid disposition in the pregnant mouse. Toxicol Appl Pharmacol. 1995;132:103–114.
CrossRef +
Therapontos
C, Erskine
L, Gardner
ER
et al Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. Proc Natl Acad Sci U S A. 2009;106:8573–8578.
CrossRef +
Thompson
CJS Mystery and Lore of Monsters. London: Williams and Norgate; 1930.
+
Thornburg
KL, O’Tierney
PF, Louey
S The placenta is a programming agent for cardiovascular disease. Placenta. 2010;31(suppl):S54–S59.
CrossRef +
Tomson
T, Battino
D Teratogenicity of antiepileptic drugs: state of the art. Curr Opin Neurol. 2005;18:135–140.
CrossRef +
Ton
C, Lin
Y, Willett
C Zebrafish as a model for developmental neurotoxicity testing. Birth Defects Res A Clin Mol Teratol. 2006;76:553–567.
CrossRef +
Toppari
J, Larsen
JC, Christiansen
P
et al Male reproductive health and environmental xenoestrogens. Environ Health Perspect. 1996;104 (suppl 4):741–776.
CrossRef +
Toppari
J, Virtanen
HE, Main
KM, Skakkebaek
NE Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection. Birth Defects Res A Clin Mol Teratol. 2010;88:910–919.
CrossRef +
Trainor
PA, Krumlauf
R Hox genes, neural crest cells and branchial arch patterning. Curr Opin Cell Biol. 2001;13:698–705.
CrossRef +
Tuthill
DP, Stewart
JH, Coles
EC
et al Maternal cigarette smoking and pregnancy outcome. Paediatr Perinatol Epidemiol. 1999;13:245–253.
CrossRef +
US Environmental Protection Agency. Health Effects Test Guidelines. OPPTS 870.3700. Prenatal Developmental Toxicity Study. EPA 712-C-98-207; 1998a.
+
US Environmental Protection Agency. Endocrine Screening Program: Statement of Policy. Fed Reg. 1998b;63(248):71542–71568.
+
US Environmental Protection Agency. Guidelines for Developmental Toxicity Risk Assessment; Notice. Fed Reg. 1991a;56:63798–63826.
+
US Environmental Protection Agency. Pesticide Assessment Guidelines, subdivision F, Hazard Evaluation: human and domestic animals, addendum 10: neurotoxicity. Series 81, 82, and 83. EPA 540/09-91-123 PB 91-154617; 1991b.
+
US Environmental Protection Agency. Special Report on Environmental Endocrine Disruption: An Effects Assessment and Analysis. US Environmental Protection Agency, EPA/630/R-012. Washington, DC: USEPA; February 1997.
+
US Environmental Protection Agency. Toxic Substance Control Act Testing Guidelines. Final Rules: preliminary developmental toxicity screen. Fed Reg. 1985;50:39428–39429.
+
US Food and Drug Administration. Guidelines for Reproduction Studies for Safety Evaluation of Drugs for Human Use. Rockville, MD: USFDA; 1966.
+
US Food and Drug Administration. International Conference on Harmonization; Guideline on Detection of Toxicity to Reproduction for Medicinal Products; Availability; Notice. Fed Reg. 1994;59:48746–48752.
+
US Food and Drug Administration. Labeling and prescription drug advertising: Content and format for labeling for human prescription drugs. Fed Reg. 1979;44:37434–37467.
+
US Food and Drug Administration. Guidance document. Nonclinical safety Evaluation of Pediatric Drug Products. Silver Spring, MD: FDA; 2006.
+
Vaglia
JL, Hall
BK Regulation of neural crest cell populations: occurrence, distribution and underlying mechanisms. Int J Dev Biol. 1999;43:95–110.
+
Van Maele-Fabry
G, Delhaise
F, Picard
JJ Morphogenesis and quantification of the development of post-implantation mouse embryos. Toxicol In Vitro. 1990;4:149–156.
CrossRef +
Vandenberg
LN, Colborn
T, Hayes
TB
et al Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012;33:378–455.
CrossRef +
Vauloup-Fellous
C, Hubschen
JM, Abernathy
ES
et al Phylogenetic analysis of rubella viruses involved in congenital rubella infections in France between 1995 and 2009. J Clin Microbiol. 2010;48:2530–2535.
CrossRef +
Vierula
M, Niemi
M, Keiski
A
et al High and unchanged sperm counts of Finnish men. Int J Androl. 1996;19:11–17.
CrossRef +
Vogel
R, Seidle
T, Spielmann
H A modular one-generation reproduction study as a flexible testing system for regulatory safety assessment. Reprod Toxicol. 2010;29:242–245.
CrossRef +
Vojnits
K, Bremer
S Challenges of using pluripotent stem cells for safety assessments of substances. Toxicology. 2010;270:10–17.
CrossRef +
Volfe
JJ Effects of cocaine on the fetus. N Engl J Med. 1992;327:399–407.
CrossRef +
vom Saal
FS, Hughes
C An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ Health Perspect. 2005;113:926–933.
CrossRef +
vom Saal
FS, Timms
BG, Montano
MM
et al Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci U S A. 1997;94:2056–2061.
CrossRef +
Von Kries
R, Toschke
AM, Koletzko
B, Slikker
W
Jr Maternal smoking during pregnancy and childhood obesity. Am J Epidemiol. 2002;156:954–961.
CrossRef +
Wald
N Folic acid and the prevention of neural tube defects. In: Keen CL, Bendich A, Willhite CC, eds. Maternal Nutrition and Pregnancy Outcome. Ann NY Acad Sci. 1993;678:112–129.
CrossRef +
Walfisch
A, Al-maawali
A, Moretti
ME
et al Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers. J Obstet Gynaecol. 2011;31:465–472.
CrossRef +
Warkany
J Manifestations of prenatal nutritional deficiency. Vit Horm. 1945;3:73–103.
+
Warkany
J Development of experimental mammalian teratology. In: Wilson JG, Warkany J, eds. Teratology: Principles and Techniques. Chicago: University of Chicago Press; 1965:1–11.
+
Warkany
J History of teratology. In: Handbook of Teratology. Vol 1. New York: Plenum Press; 1977:3–45.
+
Warkany
J Teratology: spectrum of a science. In: Kalter H, ed. Issues and Reviews in Teratology. Vol 1. New York: Plenum Press; 1983:19–31.
+
Warkany
J Teratogen update: hyperthermia. Teratology. 1986;33:365–371.
CrossRef +
Warkany
J, Nelson
RC Appearance of skeletal abnormalities in the offspring of rats reared on a deficient diet. Science. 1940;92:383–384.
CrossRef +
Warkany
J, Schraffenberger
E Congenital malformations induced in rats by roentgen rays. Am J Roentgenol Radium Ther. 1944;57:455–463.
+
Warren
KR, Li
TK Genetic polymorphisms: impact on the risk of fetal alcohol spectrum disorders. Birth Defects Res A Clin Mol Teratol. 2005;73:195–203.
CrossRef +
Waterland
RA, Jirtle
RL Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol. 2003;23:5293–5300.
CrossRef +
Waterland
RA, Jirtle
RL Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition. 2004;20:63–68.
CrossRef +
Watkinson
WP, Millicovsky
G Effects of phenytoin on maternal heart rate in A/J mice: possible role in teratogenesis. Teratology. 1983;28:1–8.
CrossRef +
Weaver
TE, Scott
WJ
Jr Acetazolamide teratogenesis: association of maternal respiratory acidosis and ectrodactyly in C57BL/6J mice. Teratology. 1984a;30:187–193.
CrossRef +
Weaver
TE, Scott
WJ
Jr Acetazolamide teratogenesis: Interactions of maternal metabolic and respiratory acidosis in the induction of ectrodactyly in C57BL/6J mice. Teratology. 1984b;30:195–202.
CrossRef +
Welsch
F Short term methods of assessing developmental toxicity hazard. In: Kalter H, ed. Issues and Review in Teratology. Vol 5. New York: Plenum Press; 1990:115–153.
+
Welshons
WV, Nagel
SC, vom Saal
FS Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinol. 2006;147:S56–S69.
CrossRef +
White
E Death defying acts: a meeting review on apoptosis. Genes Dev. 1993;7:2277–2284.
CrossRef +
Wilcox
AJ, Weinberg
CR, O’Connor
JF
et al Incidence of early loss of pregnancy. N Engl J Med. 1988;319:189–194.
CrossRef +
Wilson
JG Experimental studies on congenital malformations. J Chron Dis. 1959;10:111–130.
CrossRef +
Wilson
JG Environment and Birth Defects. New York: Academic Press; 1973.
+
Wilson
JG Embryotoxicity of drugs in man. In: Wilson JG, Fraser FC, eds. Handbook of Teratology. New York: Plenum Press; 1977:309–355.
+
Wilson
JG, Roth
CB, Warkany
J An analysis of the syndrome of malformations induced by maternal vitamin A deficiency: effects of restoration of vitamin A at various times during gestation. Am J Anat. 1953;92:189–217.
CrossRef +
Wiltse
J Mode of action: inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin—developmental effects of valproic acid. Crit Rev Toxicol. 2005;35:727–738.
CrossRef +
Windham
GC, Hopkins
B, Fenster
L, Swan
SH Prenatal active or passive tobacco smoke exposure and the risk of preterm delivery or low birth weight. Epidemiology. 2000;11:427–433.
CrossRef +
Wisborg
K, Kesmodel
U, Henriksen
TB
et al Exposure to tobacco smoke in utero and the risk of stillbirth and death ain the first year of life. Am J Epidemiol. 2001;154:322–327.
CrossRef +
Wolf
CJ, Takacs
ML, Schmid
JE
et al Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths. Toxicol Sci. 2008;106:162–171.
CrossRef +
Yang
L, Ho
NY, Alshut
R
et al Zebrafish embryos as models for embryotoxic and teratological effects of chemicals. Reprod Toxicol. 2009;28:245–253.
CrossRef +
Yelin
R, Schyr
RB, Kot
H
et al Ethanol exposure affects gene expression in the embryonic organizer and reduces retinoic acid levels. Dev Biol. 2005;279:193–204.
CrossRef +
You
L, Casanova
M, Archibeque-Engel
S
et al Impaired male sexual development in perinatal Sprague-Dawley and Long-Evans Hooded rats exposed in utero and lactationally to pp′-DDE. Toxicol Sci. 1998;45:162–173.
+
Young
JF Physiologically-based pharmacokinetic model for pregnancy as a tool for investigation of developmental mechanisms. Comput Biol Med. 1998;28:359–364.
CrossRef +
Yu
M-L, Hsu
C-C, Gladen
B, Rogan
WJ In utero PCB/PCDF exposure: relation of developmental delay to dysmorphology and dose. Neurotoxicol Teratol. 1991;13:195–202.
CrossRef +
Zakany
J, Tuggle
CK, Nguyen-Huu
CM The use of lacZ gene fusions in the studies of mammalian development: developmental regulation of mammalian homeobox genes in the CNS. J Physiol Paris. 1990;84:21–26.
+
Zeisel
SH What choline metabolism can tell us about the underlying mechanisms of fetal alcohol spectrum disorders. Mol Neurobiol. 2011;44:185–191.
CrossRef +
Zoeller
RT, Crofton
KM Mode of action: developmental thyroid hormone insufficiency—neurological abnormalities resulting from exposure to propylthiouracil. Crit Rev Toxicol. 2005;35:771–781.
CrossRef